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Abstract 
 
LiNH2BH3-promoted reductive opening of 8-substituted phenylglycinol-derived oxazolopiperidone 
lactams leads to enantiopure 4-substituted-5-aminopentanols, which are used as starting building blocks 
in the synthesis of the Haliclona alkaloids haliclorensin C, haliclorensin, and halitulin (formal). The 
starting lactams are easily accessible by a cyclocondensation reaction of (R)-phenylglycinol with 
racemic -subtituted -oxoesters, in a process that involves a dynamic kinetic resolution. 
 
 
Phenylglycinol-derived oxazolopiperidone lactams have proven to be multipurpose enantiomeric 
scaffolds for the synthesis of diversely substituted piperidine, indolizidine, quinolizidine, 
decahydroquinoline, tetrahydroisoquinoline, and tetrahydro--carboline derivatives, as well as complex 
polycyclic piperidine-containing alkaloids.
1
 These lactams are easily accessible by a cyclocondensation 
reaction between the amino alcohol and a -oxoacid derivative and, due to their versatile functionality 
and conformational rigidity, allow the regio- and stereocontrolled introduction of substituents at the 
 2 
different positions of the piperidine ring to ultimately provide enantiopure piperidine derivatives bearing 
virtually any type of substitution pattern.  
Taking into account that the stereocontrolled generation of chiral centers is generally more efficient 
and easier to accomplish in conformationally rigid cyclic systems than in acyclic compounds, we 
envisaged the above -lactams as potential building blocks for the synthesis of enantiopure substituted 
1,5-aminoalcohols or -amino acid derivatives. Our approach would involve the stereoselective 
formation of the appropriate substituted lactam and then the opening of the lactam ring, with prior or 
subsequent removal of the phenylethanol moiety of the chiral inductor. 
We report herein our studies aimed at developing this concept from lactams 2, which incorporate a 
substituent at the 5 position of the 2-piperidone ring, and illustrate the usefulness of the resulting 
substituted linear-chain amino intermediates in the total synthesis of natural products. 
Lactams 2 were stereoselectively prepared
2 
by cyclocondensation of racemic -oxoesters 1,3 which 
bear a substituent (alkyl, phenyl, benzyl) at the epimerizable carbon  to the aldehyde carbonyl group, 
with (R)-phenylglycinol, in a process that involves a dynamic kinetic resolution of the racemic 
substrate
4,5
 (Scheme 1).  
 
Scheme 1. Synthesis of Enantiopure 4-Substituted 5-Aminopentanoic Acid Derivatives 
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Initially, the conversion of lactams 2 into functionalized linear-chain amino derivatives was performed 
by the four-step sequence outlined in Scheme 1, involving the hydrolytic opening of a 2-piperidone as 
the key step. Thus, removal of the chiral auxiliary from lactams 2a and 2b was accomplished by 
successive treatment with triethylsilane in the presence of TiCl4, which brought about the reductive 
cleavage of the oxazolidine C–O bond, and sodium in liquid NH3, which caused the cleavage of the 
benzylic C–N bond. After the resulting N-unsubstituted 2-piperidones 4a and 4b were converted to the 
corresponding N-Boc derivatives 5a and 5b, a final alkaline hydrolysis with lithium hydroxide in 
aqueous THF at room temperature,
6
 followed by esterification of the resulting crude -amino acids with 
trimethylsilyldiazomethane, led to esters 6a and 6b. The overall process 1 → 6 can be envisaged as a 
reductive amination of racemic aldehyde-esters 1 using a chiral latent form of ammonia, with 
concomitant dynamic kinetic resolution. 
A more straightforward preparation of substituted linear-chain functionalized amino derivatives was 
accomplished by treatment of lactams 2 with lithium amidotrihydroborate (LiNH2BH3), which was 
generated in situ by deprotonation of the borane-ammonia complex with n-BuLi
7
 (Scheme 2).  
 
Scheme 2. Synthesis of Enantiopure 4-Substituted 5-Aminoalcohols 
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Although this reagent has been used to reduce acyclic tertiary amides to primary alcohols,
8
 N-alkyl -
lactams are usually reduced to the corresponding cyclic amines,
9
 and there are only a few examples in 
the literature of the LiNH2BH3 reductive opening of crowded -lactams.
10
 
Under LiNH2BH3 reduction conditions, bicyclic lactams 2a–e were directly converted into N-
substituted 1,5-aminoalcohols 7a–e in an unprecedented process featuring the reductive opening of both 
the oxazolidine and lactam rings,
11 
most probably through a stepwise sequence involving a 3-aza-Grob 
fragmentation,
12
 as outlined in Scheme 3.  
 
Scheme 3. Proposed Mechanism for the LiNH2BH3 Reduction of Lactams 2 
 
 
A subsequent removal of the phenylethanol moiety by hydrogenolysis, followed by protection of the 
resulting primary amines, led to the enantiopure N-protected 4-substituted-5-aminopentanols 8–10. 
These aminoalcohols possess a stereogenic center with a well-defined configuration at the position  to 
the nitrogen atom, a structural motif (when R = methyl) found in several macrocyclic alkaloids, such as 
haliclorensin C,
13
 halitulin,
14
 and haliclorensin,
15
 isolated from the marine sponge Haliclona tulearensis. 
The synthesis of these alkaloids from the above aminoalcohols would require the latter to be converted 
into appropriate long-chain secondary amino derivatives bearing two terminal alkene functionalities, 
which would allow the target azacyclic structures to be assembled using a ring-closing metathesis 
reaction as the key step.  
Thus, the methyl substituted aminopentanol 9a was envisaged as the N1–C6 fragment of haliclorensin 
C (Scheme 4). Alkylation of 9a with 10-undecenyl bromide, followed by Dess–Martin oxidation of the 
resulting alcohol 11 and subsequent Wittig methylenation from the resulting aldehyde, gave the required 
N-hexenyl N-undecenyl amino derivative 12. As expected, a ring-closing metathesis reaction provided 
the 16-membered azacycle 13
16
 in excellent yield. Removal of the nosyl group followed by catalytic 
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hydrogenation completed the first total synthesis of haliclorensin C. Unfortunately, haliclorensin C had 
been isolated
13
 only in minute amounts (2 mg), and the 
1
H and 
13
C NMR spectra included in the paper 
show considerable contamination. These spectra probably correspond to a protonated sample since they 
essentially coincide with the spectra of the hydrochloride of our synthetic material (see Experimental 
Section and Supporting Information). 
 
Scheme 4. Enantioselective Synthesis of Haliclorensin C  
 
 
A conceptually similar strategy from the same aminoalcohol 9a, but using 4-pentenyl bromide as the 
alkylating agent, can be used for the synthesis of halitulin and isohaliclorensin,
17
 the latter being the 
structure initially proposed
15a
 for haliclorensin (Scheme 5). Oxidation of alcohol 15 under Dess–Martin 
conditions, followed by Wittig methylenation of the
 
resulting aldehyde, led to the N-hexenyl N-pentenyl 
amino derivative 16, from which the synthesis of halitulin and isohaliclorensin has already been 
reported
14c,17a
 using a ring-closing metathesis reaction to construct the azacyclodecane ring.  
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Scheme 5. Formal Syntheses of Halitulin and Isohaliclorensin 
 
 
 
Similarly, the protected aminopentanol 10a was envisaged as the N5–C10 fragment of haliclorensin. 
The synthesis of this alkaloid from 10a was also planned via a ring-closing metathesis reaction from an 
appropriate long-chain amino derivative, 21, bearing two terminal carbon–carbon double bonds. The 
synthesis is outlined in Scheme 6.  
 
Scheme 6. Enantioselective Synthesis of Haliclorensin 
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Alkylation of the tosylamide moiety of the silyl derivative 17 with 3-(phthalimido)propyl iodide,
18
 
followed by removal of the silyl protecting group and, as in the above syntheses, a Dess–Martin 
oxidation–Wittig methylenation sequence, led to the orthogonally protected diamino derivative 20. 
Hydrazinolysis of the phthalimido group, followed by acylation of the resulting primary amine with 4-
pentenoyl chloride, installed the required terminal alkene functionality in 21. The synthesis of 
haliclorensin was completed by a ring-closing metathesis reaction, followed by catalytic hydrogenation 
of the carbon–carbon double bond of the resulting diazacyclotetradecane derivative 2219 and LiAlH4 
reduction, which brought about both the reductive removal of the tosyl group and the reduction of the 
lactam carbonyl. The NMR spectroscopic data of our synthetic haliclorensin were coincident with those 
reported for previously synthesized haliclorensins,
15b,c 
whereas the []22D value of our sample [– 17.2 (c 
0.5, MeOH)] was consistent with that of both the natural product
13
 [– 19 (c 0.57, MeOH)] and synthetic 
haliclorensins.
15b,c,20. 
In summary, we have developed a straightforward procedure for the preparation of enantiopure 1,5-
aminoalcohols from phenylglycinol-derived oxazolopiperidone lactams. Starting from 8-substituted 
lactams 2, lithium amidotrihydroborate (LiNH2BH3) induces the reductive opening of both the 
oxazolidine and lactam rings in a single synthetic step. A subsequent removal of the phenylethanol 
moiety by hydrogenolysis leads to 4-substituted-5-aminopentanols, whose value as chiral building 
blocks is illustrated by the synthesis of the marine alkaloids haliclorensin C, haliclorensin, and halitulin 
(formal). 
 
Experimental Section 
Methyl 4-Isopropyl-5-oxopentanoate (1c): Isovaleraldehyde (7.54 mL, 69.7 mmol) was added 
dropwise to a cooled (0 ºC) mixture of piperidine (10.3 mL, 104.5 mmol) and K2CO3 (3.47 g, 25.1 
mmol) and the mixture was stirred for 18 h at room temperature. Insoluble material was filtered through 
Celite®, and the filtrate was washed with Et2O, dried, filtered, and concentrated in vacuum to remove 
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the excess of piperidine. Methyl acrylate (7.64 mL, 84.8 mmol) was slowly added to a stirred solution of 
the resulting residue in anhydrous acetonitrile (21 mL) at 0 ºC. The mixture was stirred at reflux 
overnight. Glacial acetic acid (4.8 mL) and water (21 mL) were added, and the resulting solution was 
heated at reflux for 2 h. The mixture was allowed to cool to room temperature, the aqueous phase was 
saturated with NaCl, and the solution was extracted with Et2O. The combined organic extracts were 
dried, filtered, and concentrated to give an oil. Flash chromatography (8:2 hexane-Et2O) afforded 
compound 1c (8.7 g, 73 %) as a colorless oil: IR (film) 1738 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, 
g-HSQC) 0.97d, J = 6.8 Hz, 3H, CHCH3), 1.00 (d, J = 6.8 Hz, 3H, CHCH3), 1.74-1.83 (m, 1H, H-
3), 1.90-1.99 (m, 1H, H-3), 2.02-2.10 (m, 1H, CHMe2), 2.12-2.18 (m, 1H, H-4), 2.25 (ddd, J = 16.1, 8.5, 
7.4 Hz, 1H, H-2), 2.38 (ddd, J = 16.1, 8.9, 6.0 Hz, 1H, H-2), 3.67 (s, 3H, CH3O), 9.65 (s, 1H, CHO); 
13
C 
NMR (100.6 MHz, CDCl3) 19.3 (CH3), 19.9 (CH3), 20.8 (C-3), 28.3 (CHMe2), 31.8 (C-2), 51.3 
(CH3O), 57.3 (C-4), 173.3 (CO2), 204.4 (CHO); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C9H17O3 
173.1172; Found 173.1168.  
Methyl 4-Benzyl-5-oxopentanoate (1e): Operating as above, from 3-phenylpropanal (5.89 mL, 44.7 
mmol), piperidine (6.61 mL, 67.1 mmol), K2CO3 (2.23 g, 15.6 mmol), and methyl acrylate (7.0 mL, 
77.5 mmol) in anhydrous acetonitrile (20 mL), with subsequent treatment with a mixture of glacial 
acetic acid (5 mL) and water (20 mL), compound 1e (5.58 g, 57 %) was obtained as a yellow oil after 
flash chromatography (from 95:5 hexane-Et2O to 9:1 hexane-Et2O): IR (film) 1732 cm
-1
. 
1
H NMR (400 
MHz, CDCl3, COSY, g-HSQC) 1.76-1.85 (m, 1H, H-3), 1.93-2.01 (m, 1H, H-3), 2.34 (m, 2H, H-2), 
2.66-2.71 (m, 1H, H-4), 2.71-2.77 (m, 1H, CH2Ar), 3.02 (dd, J = 13.4, 6.6 Hz, 1H, CH2Ar), 3.65 (s, 3H, 
CH3), 7.15-7.32 (m, 5H, ArH), 9.68 d, J = 2.0 Hz, 1H, CHO); 
13
C NMR (100.6 MHz, CDCl3) 23.5 
(C-3), 31.3 (C-2), 35.1 (CH2Ar), 51.6 (CH3), 52.4 (C-4), 126.5 (C-p), 128.6, 128.8 (C-o, C-m), 138.1 
(C-i), 173.2 (CO2), 203.5 (CHO); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C13H17O3 221.1099; 
Found 221.1089.  
(3R,8S,8aR)-8-Methyl-5-oxo-3-phenyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo [3,2-a]pyridine (2a): 
Method A: A mixture of racemic oxoester 1a
21
 (565 mg, 3.92 mmol), (R)-phenylglycinol (537 mg, 3.92 
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mmol) and anhydrous Na2SO4 (2.17 g, 15.3 mmol) in Et2O (10 mL) was stirred at 0 ºC for 5 h. The 
resulting suspension was filtered, and the filtrate was concentrated under reduced pressure. The residue 
was heated at 90 ºC for 5 h under vacuum (10-15 mm Hg). Column chromatography (SiO2 previously 
washed with 7:3 hexane-Et3N; gradient from 7:3 hexane-EtOAc to EtOAc) of the residue afforded 
lactam 2a (670 mg, 74 %) and its (3R,8R,8aS) diastereoisomer (85 mg, 9 %). 2a: []22D  – 43.7 (c 1.0, 
MeOH); IR (film) 1658 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC)  1.20 (d, J = 6.3 Hz, 3H, 
CH3), 1.46-1.58 (m, 1H, H-7), 1.88-1.94 (m, 1H, H-7), 1.95-2.00 (m, 1H, H-8), 2.28-2.44 (m, 2H, H-6), 
4.00 (dd, J = 8.8, 1.2 Hz, 1H, H-2), 4.13 (dd, J = 8.8, 6.4 Hz, 1H, H-2), 4.43 (d, J = 8.8 Hz, 1H, H-8a), 
4.92 (d, J = 7.2 Hz, 1H, H-3), 7.21-7.40 (m, 5H, ArH); 
13
C NMR (100.6 MHz, CDCl3)  16.6 (CH3), 
26.9 (C-7), 31.4 (C-6), 34.5 (C-8), 59.1 (C-3), 73.7 (C-2), 93.5 (C-8a), 126.3 (C-o), 127.4 (C-p), 128.4 
(C-m), 141.5 (C-i), 167.3 (CO); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C14H18NO2 232.1332; 
Found 232.1325. Anal. Calcd for C14H17NO2: C, 72.70; H, 7.41; N, 6.06. Found: C, 72.66; H, 7.20; N, 
5.98. (3R,8R,8aS) diastereoisomer: []22D  – 115.3 (c 1.0, MeOH); IR (film) 1658 cm
-1
; 
1
H NMR (400 
MHz, CDCl3, COSY, g-HSQC)  1.18 (d, J = 6.0 Hz, 3H, CH3), 1.42-1.63 (m, 1H, H-7), 1.65-1.71 (m, 
1H, H-8), 1.80-1.85 (m, 1H, H-7), 2.34-2.44 (m, 1H, H-6), 2.53 (dd, J = 18.0, 6.0 Hz, 1H, H-6), 3.75 
(dd, J = 9.0, 7.8 Hz, 1H, H-2), 4.47 (dd, J = 9.0, 7.8 Hz, 1H, H-2), 4.60 (d, J = 8.0 Hz, 1H, H-8a), 5.25 
(t, J = 7.8 Hz, 1H, H-3), 7.20-7.45 (m, 5H, ArH); 
13
C NMR (100.6 MHz, CDCl3) 17.1 (CH3), 25.9 (C-
7), 31.5 (C-6), 34.9 (C-8), 58.4 (C-3), 72.4 (C-2), 93.7 (C-8a), 126.1 (C-o), 127.5 (C-p), 128.7 (C-m), 
139.5 (C-i), 168.7(CO). Anal. Calcd for C14H17NO2: C, 72.70; H, 7.41; N, 6.06. Found: C, 72.56; H, 
7.35; N, 5.81. 
Method B: (R)-Phenylglycinol (1.97 g, 14.4 mmol) was added to a solution of racemic oxoester 1a
21
 
(1.9 g, 14.4 mmol) in anhydrous toluene (45 mL), and the mixture was heated at reflux for 25 h with 
azeotropic elimination of water produced by a Dean-Stark apparatus. The resulting mixture was cooled 
and concentrated under reduced pressure. The residue was dissolved in CH2Cl2 and washed with 
saturated aqueous NaHCO3 solution. The combined organic extracts were dried, filtered, and 
concentrated to give an oil. Flash chromatography (SiO2 previously washed with 7:3 hexane-Et3N; 
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gradient from 7:3 hexane-EtOAc to EtOAc) afforded lactam 2a (1.7 g, 56 %) as a brown solid and its 
(3R,8R,8aS) diastereoisomer (0.55 g, 18 %).  
Method C: (R)-Phenylglycinol (190 mg, 1.39 mmol) and oxoester 1a
21
 (200 mg, 1.39 mmol) in toluene 
(4.5 mL) were mixed in a capped 10 mL microwave vessel. The mixture was heated at 110 ºC (average 
effective ramp time = 5 min). The power was set at 100 W and the pressure at 218 psi for 10 min. The 
reaction mixture was then concentrated under reduced pressure and the crude product was dissolved in 
CH2Cl2 and washed with saturated aqueous NaHCO3 solution. The organic phase was dried, filtered, 
and concentrated. Flash chromatography (SiO2 previously washed with 7:3 hexane-Et3N; gradient from 
7:3 hexane-EtOAc to EtOAc) afforded lactam 2a (185 mg, 58 %) and its (3R,8R,8aS) diastereoisomer 
(70 mg, 22 %). 
(3R,8R,8aR)-8-Isopropyl-5-oxo-3-phenyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo[3,2-a]pyridine (2c): 
Operating as described in the above Method A, from racemic oxoester 1c (1.07 g, 6.18 mmol), (R)-
phenylglycinol (848 mg, 6.18 mmol), and anhydrous Na2SO4 (3.43 g, 24.1 mmol) in Et2O (20 mL), 
lactam 2c (1.16 g, 73 %) and its (3R,8S,8aS) diastereoisomer (white solid, 180 mg, 11 %) were 
obtained after flash chromatography (SiO2 previously washed with 7:3 hexane-Et3N; gradient from 7:3 
hexane-EtOAc to EtOAc). 2c: []22D – 18.6 (c 1.2, MeOH); IR (film) 1658 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3, COSY, g-HSQC)  0.98 (d, J = 6.9 Hz, 3H, CH3), 1.07 (d, J = 6.9 Hz, 3H, CH3), 1.50-1.61 (m, 
1H, H-7), 1.76-1.83 (m, 1H, H-8), 1.86-1.93 (m, 1H, H-7), 2.08-2.16 [m, 1H, CH(CH3)2], 2.30 (ddd, J = 
17.9, 11.2, 6.8 Hz, 1H, H-6), 2.43 (ddd, J = 17.9, 6.8, 2.4 Hz, 1H, H-6), 4.01 (d, J = 9.0 Hz, 1H, H-2), 
4.14 (dd, J = 9.0, 6.6 Hz, 1H, H-2), 4.67 (d, J = 9.2 Hz, 1H, H-8a), 4.92 (d, J = 6.6 Hz, 1H, H-3), 7.22-
7.32 (m, 5H, ArH); 
13
C NMR (100.6 MHz, CDCl3) 17.7 (CH3), 19.6 (C-7), 20.5 (CH3), 27.7 
[CH(CH3)2], 31.6 (C-6), 44.6 (C-8), 58.9 (C-3), 73.8 (C-2), 90.6 (C-8a), 126.3 (C-o), 127.4 (C-p), 128.5 
(C-m), 141.6 (C-i), 167.3 (CO); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C16H22NO2 260.1645; 
Found 260.1640. (3R,8S,8aS) diastereoisomer: []22D – 87.7 (c 1.2, MeOH); IR (film) 1666 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3, COSY, g-HSQC)  0.96 (dd, J = 6.9, 2.1 Hz, 3H, CH3), 1.05 (dd, J = 6.9, 2.1 
Hz, 3H, CH3), 1.47-1.63 (m, 2H, H-7, H-8), 1.83-1.88 (m, 1H, H-7), 2.01-2.05 [m, 1H, CH(CH3)2], 
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2.30-2.39 (m, 1H, H-6), 2.59 (dm, J = 18.5 Hz, 1H, H-6), 3.74 (dt, J = 8.2, 2.1 Hz, 1H, H-2), 4.48 (dt, J 
= 8.2, 2.1 Hz, 1H, H-2), 4.80 (dd, J = 8.2, 2.1 Hz, 1H, H-8a), 5.26 (t, J = 7.8 Hz, 1H, H-3), 7.26-7.37 
(m, 5H, ArH); 
13
C NMR (100.6 MHz, CDCl3) 18.0 (CH3), 19.2 (C-7), 20.6 (CH3), 28.1 [CH(CH3)2], 
31.7 (C-6), 45.3 (C-8), 58.1 (C-3), 72.4 (C-2), 90.7 (C-8a), 126.1 (C-o), 127.5 (C-p), 128.8 (C-m), 139.7 
(C-i), 169.1 (CO); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C16H22NO2 260.1645; Found 260.1639. 
Method B: Operating as described in the above Method B, from racemic oxoester 1c (1.09 g, 6.32 
mmol) and (R)-phenylglycinol (867 mg, 6.32 mmol) in toluene (20 mL), lactam 2c (white solid, 1.06 g, 
64 %) and its (3R,8S,8aS) diastereoisomer (230 mg, 14 %) were obtained after flash chromatography 
(SiO2 previously washed with 7:3 hexane-Et3N; gradient from 7:3 hexane-EtOAc to EtOAc).  
(3R,8R,8aR)-8-Benzyl-5-oxo-3-phenyl-2,3,6,7,8,8a-hexahydro-5H-oxazolo [3,2-a] pyridine (2e): 
Operating as described in the above Method A, from racemic oxoester 1e (626 mg, 2.84 mmol), (R)-
phenylglycinol (390 mg, 2.84 mmol), and anhydrous Na2SO4 (1.57 g, 11.1 mmol) in Et2O (9 mL), 
lactam 2e (478 mg, 55 %) and its (3R,8S,8aS) diastereoisomer (white solid, 80 mg, 9 %) were obtained 
after flash chromatography (SiO2 previously washed with 7:3 hexane-Et3N; gradient from 7:3 hexane-
EtOAc to EtOAc). 2e: []22D – 144.8 (c 0.1, MeOH); IR (film) 1658 cm
-1
; 
1
H NMR (400 MHz, CDCl3, 
COSY, g-HSQC)  1.39-1.51 (m, 1H, H-7), 1.83-1.88 (m, 1H, H-7), 2.08-2.13 (m, 1H, H-8), 2.21 (ddd, 
J = 18.2, 11.6, 6.9 Hz, 1H, H-6), 2.36 (ddd, J = 18.2, 6.9, 1.8 Hz, 1H, H-6), 2.54 (dd, J = 13.5, 9.7 Hz, 
1H, CH2Ar), 3.27 (dd, J = 13.5, 3.5 Hz, 1H, CH2Ar), 4.06 (dd, J = 9.0, 1.2 Hz, 1H, H-2), 4.18 (dd, J = 
9.0, 6.4 Hz, 1H, H-2), 4.58 (d, J = 9.0 Hz, 1H, H-8a), 4.94 (d, J = 6.4 Hz, 1H, H-3), 7.23-7.35 (m, 10H, 
ArH); 
13
C NMR (100.6 MHz, CDCl3) 23.4 (C-7), 31.3 (C-6), 37.2 (CH2Ar), 41.0 (C-8), 59.1 (C-3), 
73.9 (C-2), 91.9 (C-8a), 126.3 (C-o), 126.5 (C-p), 127.5 (C-p), 128.5 and 129.2 (2C-m, C-o), 138.2 and 
141.4 (2C-i), 167.2 (CO); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C20H22NO2 308.1645; Found 
308.1645. (3R,8S,8aS) diastereoisomer: []22D – 45.0 (c 0.15, MeOH); IR (film) 1659 cm-1; 
1
H NMR 
(400 MHz, CDCl3, COSY, g-HSQC)  1.43-1.55 (m, 1H, H-7), 1.79-1.90 (m, 2H, H-7, H-8), 2.26 (dd, J 
= 12.1, 6.6 Hz, 1H, H-6), 2.47-2.54 (m, 2H, H-6, CH2Ar), 3.23 (dd, J = 13.5, 3.4 Hz, 1H, CH2Ar), 3.81 
(dd, J = 8.9, 7.8 Hz, 1H, H-2), 4.53 (dd, J = 8.9, 7.8 Hz, 1H, H-2), 4.76 (d, J = 8.4 Hz, 1H, H-8a), 5.28 
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(t, J = 7.8 Hz, 1H, H-3), 7.19-7.36 (m, 10H, ArH); 
13
C NMR (100.6 MHz, CDCl3) 22.4 (C-7), 31.4 
(C-6), 37.7 (CH2Ar), 41.6 (C-8), 58-5 (C-3), 72.5 (C-2), 92.1 (C-8a), 126.1 (C-o), 126.5 (C-p), 127.6 
(C-p), 128.5 (C-o), 128.8, 129.4 (C-m), 138.4 and 139.5 (2C-i), 168.7 (CO); HRMS (ESI-TOF) m/z: [M 
+ H]
+
 Calcd for C20H22NO2 308.1645; Found 308.1644. 
Method B: Operating as in the preparation of 2a in the above Method B, from racemic aldehyde ester 1e 
(627 mg, 2.85 mmol) and (R)-phenylglycinol (391 mg, 2.85 mmol) in toluene (9 mL), lactam 2e (white 
solid, 483 mg, 55 %) and its (3R,8S,8aS) diastereoisomer (white solid, 122 mg, 14 %) were obtained 
after flash chromatography (SiO2 previously washed with 7:3 hexane-Et3N; gradient from 7:3 hexane-
EtOAc to EtOAc). 
(S)-[(1R)-2-Hydroxy-1-phenylethyl]-5-methyl-2-piperidone (3a): Triethylsilane (0.52 mL, 3.24 
mmol) and TiCl4 (0.52 mL, 4.76 mmol) were added to a solution of lactam 2a (500 mg, 2.16 mmol) in 
anhydrous CH2Cl2 (35 mL), and the mixture was stirred at 50 ºC for 24 h. Then, additional TiCl4 (0.52 
mL, 4.76 mmol) and triethylsilane (0.52 mL, 3.24 mmol) were added and the stirring was continued at 
50 ºC for 24 h. The mixture was poured into saturated aqueous NaHCO3 (100 mL). The aqueous phase 
was filtered over Celite
®
 and extracted with CH2Cl2. The combined organic extracts were dried, filtered, 
and concentrated to give a residue, which was chromatographed (from 8:2 hexane-EtOAc to EtOAc) to 
afford 3a
22
 (315 mg, 63 %) as a colorless oil: []22D – 150.4 (c 0.1, MeOH); []
22
D – 88.3 (c 1.1, 
CH2Cl2), lit.
22
 []D – 86.8 (c 1.1, CH2Cl2); IR (film) 3372, 1616 cm
-1
; 
1
H NMR (400 MHz, CDCl3, 
COSY, g-HSQC) 0.93 (d, J = 6.4 Hz, 3H, CH3), 1.44-1.54 (m, 1H, H-4), 1.77-1.86 (m, 2H, H-4, H-5), 
2.48 (ddd, J = 17.9, 11.4, 6.5 Hz, 1H, H-3), 2.59 (ddd, J = 17.9, 6.3, 2.9 Hz, 1H, H-3), 2.85 (dd, J = 
11.8, 10.2 Hz, 1H, H-6), 2.98 (ddd, J = 11.8, 4.8, 2.1 Hz, 1H, H-6), 4.09 (dd, J = 11.4, 9.6 Hz, 1H, 
CH2O), 4.17 (dd, J = 11.4, 5.1 Hz, 1H, CH2O), 5.81 (dd, J = 9.6, 5.1 Hz, 1H, CHN), 7.17-7.38 (m, 5H, 
ArH); 
13
C-NMR (100.6 MHz, CDCl3)  18.6 (CH3), 28.9 (C-5), 29.1 (C-4), 32.0 (C-3), 50.3 (C-6), 58.5 
(CHN), 61.6 (CH2O), 127.6 (C-o), 127.7 (C-p), 128.7 (C-m), 137.0 (C-i), 171.5 (CO); HRMS (ESI-
TOF) m/z: [M + H]
+
 Calcd for C14H20NO2 234.1489; Found 234.1484.  
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(S)-5-Ethyl-[(1R)-2-hydroxy-1-phenylethyl]-2-piperidone (3b): Operating as above, from lactam 2b 
(500 mg, 2.12 mmol) in CH2Cl2 (32 mL), TiCl4 (1.20 mL, 11.03 mmol), and Et3SiH (1.02 mL, 9.54 
mmol), lactam 3b
22
 was obtained (316 mg, 60 %) after flash chromatography (from hexane-EtOAc 8:2 
to EtOAc-EtOH 8:2) as a yellow oil: []22D – 127.2 (c 0.9, EtOH), []
22
D – 73.5 (c 1.1, CH2Cl2), lit.
22
 
[]D – 74.2 (c 1.1, CH2Cl2); IR (film) 3360, 1617 cm
-1
; 
1
H NMR (400 MHz, CDCl3, g-HSQC) 0.84 (t, 
J = 7.6 Hz, 3H, CH3CH2), 1.17-1.35 (m, 2H, CH3CH2), 1.37-1.49 (m, 1H, H-4), 1.50-1.60 (m, 1H, H-5), 
1.88-1.93 (m, 1H, H-4), 2.44 (ddd, J = 18.0, 10.4, 7.2 Hz, 1H, H-3), 2.57 (ddd, J = 18.0, 6.0, 3.6 Hz, 1H, 
H-3), 2.90 (dd, J = 12.0, 9.6 Hz, 1H, H-6), 3.03 (ddd, J = 12.0, 5.0, 2.0 Hz, 1H, H-6), 4.05 (t, J = 10.4 
Hz, 1H, CH2O), 4.16 (dd, J = 11.6, 5.0 Hz, 1H, CH2O), 5.86 (dd, J = 9.6, 5.0 Hz, 1H, CHN), 7.20-7.35 
(m, 5H, ArH); 
13
C NMR (100.6 MHz, CDCl3) 11.4 (CH3CH2), 26.0 (CH3CH2), 26.5 (C-4), 31.8 (C-3), 
35.6 (C-5), 48.3 (C-6), 58.2 (CHN), 61.2 (CH2O), 127.5 (C-o), 127.6 (C-p), 128.6 (C-m), 137.1 (C-i), 
171.8 (CO). Anal. Calcd for C15H21NO2
.
1/2 H2O: C, 70.28; H, 8.65; N, 5.46. Found: C, 70.36; H, 8.37; 
N, 5.27. 
(S)-5-Methyl-2-piperidone (4a): Into a three-necked, 100 mL, round-bottomed flask equipped with a 
coldfinger condenser charged with dry-ice acetone were condensed 30 mL of NH3 at – 78 ºC. A solution 
of 3a (290 mg, 1.24 mmol) in dry THF (5 mL) was added, and the temperature was raised to – 33 ºC. 
Sodium metal was added in small portions until the blue color persisted, and the mixture was stirred at – 
33 ºC for 3 minutes. The reaction was quenched by addition of solid NH4Cl until the blue color 
disappeared, and then the mixture was stirred at room temperature for 5 h. CH2Cl2 was added, the solid 
was filtered, and the solvent was removed under reduced pressure. The resulting oil was 
chromatographed (from 8:2 hexane-EtOAc to 8:2 EtOAc-EtOH) to afford 4a
23
 (93 mg, 66 %): []22D – 
29.0 (c 0.55, MeOH), []22D – 80.0 (c 1.0, CHCl3), lit.
23
 []23D – 82.5 (c 1.0, CHCl3); IR (film) 3232, 
1659 cm
-1
; 
1
H NMR (300 MHz, CDCl3, COSY, g-HSQC) 1.01 (d, J = 6.6 Hz, 3H, CH3), 1.45-1.51 
(m, 1H, H-4), 1.83-1.99 (m, 2H, H-4, H-5), 2.34 (ddd, J = 17.8, 10.8, 6.4 Hz, 1H, H-3), 2.43 (ddd, J = 
17.8, 6.4, 3.5 Hz, 1H, H-3), 2.92 (t, J = 10.8 Hz, 1H, H-6), 3.26-3.33 (m, 1H, H-6), 6.10 (br.s, 1H, NH); 
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13
C NMR (75.4 MHz, CDCl3) 18.2 (CH3), 28.0 (C-5), 28.8 (C-4), 30.6 (C-3), 48.8 (C-6), 172.6 (CO); 
HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C6H12NO 114.0914; Found 114.0913.  
(S)-5-Ethyl-2-piperidone (4b): Operating as above, from lactam 3b (300 mg, 1.21 mmol) in THF (5 
mL), sodium, and liquid NH3 (35 mL) at – 33 ºC for 5 minutes, lactam 4b
24
 was obtained (119 mg, 77 
%) after column chromatography (from 8:2 hexane-EtOAc to 8:2 EtOAc-EtOH): []22D – 58.3 (c 0.75, 
MeOH); IR (film) 1665 cm
-1
; 
1
H NMR (300 MHz, CDCl3, COSY, g-HSQC) 0.95 (t, J = 7.5 Hz, 3H, 
CH3CH2), 1.34-1.50 (m, 3H, CH3CH2, H-4), 1.62-1.78 (m, 1H, H-5), 1.87-1.98 (m, 1H, H-4), 2.25-2.50 
(m, 2H, H-3), 2.94 (t, J = 12.0 Hz, 1H, H-6), 3.35 (m, 1H, H-6), 5.93 (br.s, 1H, NH); 
13
C NMR (75.4 
MHz, CDCl3) 11.4 (CH3CH2), 25.9 (CH3CH2), 26.6 (C-4), 30.7 (C-3), 34.7 (C-5), 47.3 (C-6), 172.7 
(CO); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C7H14NO 128.1070; Found 128.1067. 
(S)-1-(tert-Butoxycarbonyl)-5-methyl-2-piperidone (5a): n-BuLi (1.6 M in hexanes, 0.55 mL, 0.88 
mmol) was added at – 78 ºC to a solution of lactam 4a (100 mg, 0.88 mmol) in THF (2.5 mL), and the 
mixture was stirred at this temperature for 30 minutes. Then, a cooled (– 78 ºC) solution of di-tert-butyl 
dicarbonate (289 mg, 1.32 mmol) in dry THF (1.2 mL) was added, and the resulting mixture was stirred 
for 90 minutes at this temperature. Saturated aqueous NH4Cl was added, and the resulting mixture was 
extracted with EtOAc. The combined organic extracts were dried and concentrated. The residue was 
chromatographed (95:5 hexane-EtOAc) affording lactam 5a (150 mg, 80 %) as a colorless oil: []22D – 
19.5 (c 0.3, CHCl3); IR (film) 1770, 1715 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 1.04 
(d, J = 6.6 Hz, 3H, CH3), 1.41-1.50 (m, 1H, H-4), 1.52 [s, 9H, (CH3)3], 1.84-1.92 (m, 1H, H-4), 1.93-
2.03 (m, 1H, H-5), 2.47 (ddd, J = 17.4, 10.8, 6.5 Hz, 1H, H-3), 2.57 (ddd, J = 17.4, 6.5, 4.0 Hz, 1H, H-
3), 3.11 (dd, J = 12.6, 10.4 Hz, 1H, H-6), 3.79 (ddd, J = 12.6, 4.8, 2.0 Hz, 1H, H-6); 
13
C NMR (100.6 
MHz, CDCl3) 18.7 (CH3), 28.0 [(CH3)3], 28.7 (C-4), 28.7 (C-5), 34.2 (C-3), 52.8 (C-6), 82.8 
[C(CH3)3], 152.7 (NCO), 172.6 (CO); HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for C11H19NO3Na 
236.1257; Found 236.1258. 
(S)-1-(tert-Butoxycarbonyl)-5-ethyl-2-piperidone (5b): Operating as above, from lactam 4b (180 mg, 
1.4 mmol), n-BuLi (1.6 M in hexanes, 0.57 mL, 1.4 mmol), and di-tert-butyl dicarbonate (309 mg, 1.4 
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mmol) in THF (5 mL), lactam 5b was obtained (221 mg, 70 %) as a colorless oil after flash 
chromatography (from 9:1 hexane-EtOAc to 1:1 hexane-EtOAc): 
1
H NMR (400 MHz, CDCl3, COSY, 
g-HSQC) 0.96 (t, J = 7.5 Hz, 3H, CH3CH2), 1.30-1.46 (m, 3H, CH3CH2, H-4), 1.53 [s, 9H, (CH3)3], 
1.68-1.77 (m, 1H, H-5), 1.89-1.98 (m, 1H, H-4), 2.45 (ddd, J = 17.3, 10.6, 6.4 Hz, 1H, H-3), 2.55 (ddd, 
J = 17.3, 6.4, 4.3 Hz, 1H, H-3), 3.17 (dd, J = 12.7, 10.1 Hz, 1H, H-6), 3.82 (ddd, J = 12.7, 4.8, 1.7 Hz, 
1H, H-6); 
13
C NMR (100.6 MHz, CDCl3) 11.3 (CH3CH2), 26.2 (C-4), 26.3 (CH3CH2), 28.0 [(CH3)3], 
34.1 (C-3), 35.2 (C-5), 50.9 (C-6), 82.8 [C(CH3)3], 152.8 (NCO), 171.5 (CO); HRMS (ESI-TOF) m/z: 
[M – tBu]+ Calcd for C8H12NO3 170.0812; Found 170.0808. 
Methyl (S)-5-[(tert-Butoxycarbonyl)amino]-4-methylpentanoate (6a): A solution of LiOH (50.2 mg, 
1.20 mmol) in water (1.25 mL) was added to a solution of lactam 5a (85 mg, 0.40 mmol) in THF (19 
mL), and the mixture was stirred at room temperature for 4 h. THF was removed under reduced 
pressure, and the residue was dissolved in Et2O. The organic extract was washed with aqueous 1 N HCl, 
dried, filtered, and concentrated to afford a carboxylic acid (85 mg) as a colorless oil, which was used 
without purification in the next step: 
1
H NMR (400 MHz, CDCl3) 0.91 (d, J = 6.8 Hz, 3H, CH3), 1.44 
[s, 10H, (CH3)3, CH2) 1.58-1.76 (m, 2H), 2.32-2.45 (m, 2H), 2.95-3.05 (m, 2H), 4.65 (br.s, 1H, NH); 
HRMS (ESI-TOF) m/z: [M - H]
+
 Calcd for C11H20NO4 230.1392; Found: 230.1397. TMSCHN2 (0.28 
mL, 0.55 mmol) was added at 0 ºC to a solution of the above carboxylic acid (85 mg) in toluene-
methanol (2.5:1, 12.3 mL), and the mixture was stirred at this temperature for 1 h, quenched with some 
drops of AcOH, and concentrated under reduced pressure to afford pure ester 6a (88 mg, 90 %): []22D – 
5.45 (c 0.8, MeOH); IR (film) 3375, 1735, 1715 cm-1; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 
0.85d, J = 6.6 Hz, 3H, CH3), 1.38 [s, 10H, (CH3)3, H-3], 1.52-1.61 (m, 1H, H-4), 1.62-1.71 (m, 1H, 
H-3), 2.20-2.37 (m, 2H, H-5), 2.92-3.02 (m, 2H, H-2), 3.61 (s, 3H, CH3O), 4.71 (br.s, 1H, NH); 
13
C 
NMR (100.6 MHz, CDCl3) 17.1 (CH3), 28.3 [(CH3)3], 28.9 (C-3), 31.4 (C-5), 33.2 (C-4), 45.9 (C-2), 
51.4 (CH3O), 78.9 [C(CH3)3], 156.0 (NCO), 174.1 (CO2); HRMS (ESI-TOF) m/z: [M + Na]
+
 Calcd for 
C12H23NO4Na 268.1519; Found 268.1527.  
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Methyl (S)-5-[(tert-Butoxycarbonyl)amino]-4-ethylpentanoate (6b): Operating as above, from lactam 
5b (80 mg, 0.35 mmol) in THF (1.7 mL) and a solution of LiOH (44.3 mg, 1.06 mmol) in water (1.1 
mL), a carboxylic acid (80 mg) was obtained as a colorless oil: 
1
H NMR (400 MHz, CDCl3, COSY, g-
HSQC) 0.90t, J = 7.5 Hz, 3H, CH3CH2), 1.25-1.36 (m, 2H, CH3CH2), 1.44 [s, 9H, (CH3)3], 1.43-1.48 
(m, 1H, H-4), 1.55-1.67 (m, 2H, H-3), 2.30-2.42 (t, J = 7.6 Hz, 2H, H-2), 2.90-3.17 (m, 2H, H-5), 6.07 
(br.s, 1H, NH); 
13
C NMR (100.6 MHz, CDCl3) 10.8 (CH3CH2), 24.0 (CH3CH2), 25.9 (C-3), 28.4 
[(CH3)3], 31.3 (C-2), 39.3 (C-4), 42.9 (C-5), 79.3 [C(CH3)3], 156.2 (NCO), 179.0 (CO2); HRMS (ESI-
TOF) m/z: [M + Na]
+
 Calcd for C12H23NO4Na 268.1519; Found 268.1519. Operating as in the 
preparation of 6a, from the above crude carboxylic acid (80 mg) and TMSCHN2 (0.24 mL, 0.47 mmol) 
in a mixture of toluene-methanol (2.5:1, 11 mL), ester 6b (73 mg, 80 %) was obtained: []22D – 8.4 (c 
0.58, MeOH); IR (film) 3371, 1740, 1715 cm-1; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 
0.90t, J = 7.2 Hz, 3H, CH3), 1.32 (m, 2H, CH3CH2), 1.44 [s, 9H, (CH3)3], 1.46 (m, 1H, H-4), 1.62 
(m, 2H, H-3), 2.34 (t, J = 7.7 Hz, 2H, H-2), 3.02 (m, 1H, H-5), 3.09 (m, 1H, H-5), 3.70 (s, 3 H, CH3O), 
4.67 (br.s, 1H, NH); 
13
C NMR (100.6 MHz, CDCl3) 10.8 (CH3), 23.9 (CH3CH2), 26.0 (C-3), 28.3 
[(CH3)3], 31.2 (C-2), 39.3 (C-4), 42.9 (C-5), 51.5 (CH3O), 79.0 [(CH3)3], 156.0 (NCO), 174.2 (CO2); 
HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C13H26NO4 260.1856; Found 260.1852. 
(S)-5-{[(1R)-2-Hydroxy-1-phenylethyl]amino}-4-methyl-1-pentanol (7a): n-BuLi (4.13 mL of a 2.5 
M solution in hexanes, 10.3 mmol) was added to a solution of NH3
.
BH3 (319 mg, 10.3 mmol) in 
anhydrous THF (9.0 mL) at 0 ºC, and the resulting mixture was stirred at this temperature for 10 min 
and at room temperature for 15 minutes. Then, a solution of lactam 2a (555 mg, 2.40 mmol) in THF (4.5 
mL) was added, and the stirring was continued at 40 ºC for 1 h. The reaction mixture was quenched with 
H2O, and the resulting solution was extracted with Et2O. The combined organic extracts were dried, 
filtered, concentrated. Flash chromatography (from 8:2 hexane-EtOAc to 8:2 EtOAc-EtOH) of the 
residue gave (S)-[(R)-2-hydroxy-1-phenylethyl]-3-methylpiperidine
22
 (40 mg, 7%) as a colorless oil, 
and aminoalcohol 7a (425 mg, 75 %): []22D – 50.9 (c 0.68, MeOH); IR (film) 3314 cm
-1
; 
1
H NMR (400 
MHz, CDCl3, COSY, g-HSQC) 0.90dJ = 6.4 Hz, 3H, CH3), 1.13-1.21 (m, 1H, H-2), 1.44-1.56 (m, 
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2H, H-2, H-3), 1.57-1.67 (m, 2H, H-3, H-4), 2.31 (br.s, 3H, OH, NH), 2.33 (dd, J = 11.7, 6.0 Hz, 1H, H-
5), 2.43 (dd, J = 11.7, 7.0 Hz, 1H, H-5), 3.55 (dd, J = 10.6, 8.8 Hz, 1H, CH2O), 3.61 (t, J = 6.0 Hz, 2H, 
H-1), 3.70 (dd, J = 10.6, 4.4 Hz, 1H, CH2O), 3.75 (dd, J = 8.8, 4.4 Hz, 1H, CHN), 7.25-7.37 (m, 5H, 
ArH); 
13
C NMR (100.6 MHz, CDCl3) 18.6 (CH3), 29.7 (C-3), 30.3 (C-2), 32.8 (C-4), 53.4 (C-5), 62.6 
(C-1), 64.7 (CHN), 66.5 (CH2O), 127.2 (C-o), 127.6 (C-p), 128.6 (C-m), 140.4 (C-i); HRMS (ESI-TOF) 
m/z: [M + H]
+
 Calcd for C14H24NO2 238.1802; Found 238.1799. 
(S)-4-Ethyl-5-{[(1R)-2-hydroxy-1-phenylethyl]amino}-1-pentanol (7b): Operating as above, from 
lactam 2b (200 mg, 0.82 mmol), n-BuLi (1.40 mL of a 2.5 M solution in hexanes, 3.51 mmol), and 
NH3
.
BH3 (108 mg, 3.51 mmol) in anhydrous THF (3 mL), aminoalcohol 7b (165 mg, 80 %) was 
obtained after flash chromatography (from EtOAc to EtOAc-EtOH 8:2): []22D – 44.9 (c 0.16, MeOH); 
IR (film) 3330 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 0.82 (t, J = 7.6 Hz, 3H, CH3), 
1.23-1.40 (m, 3H, H-3, CH3CH2), 1.42-1.50 (m, 4H, H-2, H-3, H-4), 2.40 (dd, J = 11.6, 6.4 Hz, 1H, H-
5), 2.46 (dd, J = 11.6, 5.0 Hz, 1H, H-5), 3.41 (br.s, 3H, OH, NH), 3.57-3.64 (m, 3H, H-1, CH2O), 3.71 
(dd, J = 10.8, 4.0 Hz, 1H, CH2O), 3.77 (dd, J = 8.8, 4.0 Hz, 1H, CHN), 7.24-7.38 (m, 5H, ArH); 
13
C 
NMR (100.6 MHz, CDCl3) 11.3 (CH3), 24.9 (CH3CH2), 27.4 (C-3), 29.2 (C-2), 38.8 (C-4), 50.2 (C-5), 
60.3 (C-1), 64.8 (CHN), 66.5 (CH2O), 127.3 (C-o), 127.6 (C-p), 128.6 (C-m), 139.9 (C-i); HRMS (ESI-
TOF) m/z: [M + H]
+
 Calcd for C15H26NO2 252.1958; Found 252.1947. 
(R)-5-{[(1R)-2-Hydroxy-1-phenylethyl]amino}-4-isopropyl-1-pentanol (7c): Operating as described 
for preparation of 7a, from lactam 2c (400 mg, 1.54 mmol), n-BuLi (4.14 mL of a 2.5 M solution in 
hexanes, 6.6 mmol), and NH3
.
BH3 (205 mg, 6.6 mmol) in anhydrous THF (9 mL), (S)-[(R)-2-hydroxy-
1-phenylethyl]-3-isopropylpiperidine (30 mg, 7 %) and aminoalcohol 7c (292 mg, 71 %) were 
obtained as colorless oils after flash chromatography (from hexane-EtOAc 1:1 to EtOAc-EtOH 8:2). 
(S)-[(R)-2-hydroxy-1-phenylethyl]-3-isopropylpiperidine: []22D – 47.5 (c 0.25, MeOH); IR (film) 
3406 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 0.78-0.84 (m, 1H, H-4), 0.84 (d, J = 6.4 Hz, 
3H, CH3), 0.88 (d, J = 6.4 Hz, 3H, CH3), 1.35-1.47 [m, 3H, H-3, H-5, CH(CH3)2], 1.60-1.70 (m, 3H, H-
4, H-5, H-6), 2.03 (t, J = 10.5 Hz, 1H, H-2), 2.82 (br.m, 2H, H-2, H-6), 3.61 (dd, J = 10.3, 5.2 Hz, 1H, 
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CH2O), 3.70 (dd, J = 10.2, 5.2 Hz, 1H, CHN), 3.98 (t, J = 10.2 Hz, 1H, CH2O), 7.17-7.19 (m, 2H, ArH), 
7.30-7.37 (m, 3H, ArH); 
13
C NMR (100.6 MHz, CDCl3) 19.9 (CH3), 20.3 (CH3), 25.8 (C-5), 27.9 (C-
4), 30.9 [CH(CH3)2], 43.3 (C-3), 46.6 (C-6), 57.1 (C-2), 59.9 (CH2O), 70.3 (CHN), 127.7 (C-p), 128.0, 
128.9 (C-o, C-m), 135.5 (C-i); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C16H26NO 248.2009; Found 
248.2005. 7c: []22D – 44.9 (c 0.65, MeOH); IR (film) 3320 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, 
g-HSQC) 0.78 (d, J = 6.8 Hz, 3H, CH3), 0.82 (d, J = 6.8 Hz, 3H, CH3), 1.31-1.41 (m, 3H, H-3, H-4), 
1.45-1.52 (m, 1H, H-2), 1.54-1.61 (m, 1H, H-2),1.64-1.72 (m, 1H, CHCH3), 2.31 (dd, J = 11.8, 4.2 Hz, 
1H, H-5), 2.48 (dd, J = 11.8, 7.7 Hz, 1H, H-5), 3.54-3.65 (m, 3H, H-1, CH2O), 3.68 (dd, J = 10.8, 4.0 
Hz, 1H, CH2O), 3.76 (dd, J = 9.1, 4.0 Hz, 1H, CHN), 7.24-7.35 (m, 5H, ArH); 
13
C NMR (100.6 MHz, 
CDCl3) 19.3 (CH3), 19.4 (CH3), 25.3 (C-3), 29.3 (CHCH3), 30.2 (C-2), 43.2 (C-4), 48.8 (C-5), 61.8 
(C-1), 64.9 (CHN), 66.5 (CH2O), 127.3 (C-o), 127.5 (C-p), 128.5 (C-m), 140.1 (C-i); HRMS (ESI-TOF) 
m/z: [M + H]
+
 Calcd for C16H28NO2 266.2115; Found 266.2109. 
(R)-5-{[(1R)-2-Hydroxy-1-phenylethyl]amino}-4-phenyl-1-pentanol (7d): Operating as described for 
preparation of 7a, from lactam 2d (200 mg, 0.68 mmol), n-BuLi (1.17 mL of a 2.5 M solution in 
hexanes, 2.93 mmol), and NH3
.
BH3 (91 mg, 2.93 mmol) in anhydrous THF (5 mL), aminoalcohol 7d 
(116 mg, 57 %) was obtained as a colorless oil after flash chromatography (from hexane-EtOAc 1:1 to 
EtOAc-EtOH 8:2): []22D – 48.1 (c 0.4, MeOH); IR (film) 3323 cm
-1
; 
1
H NMR (400 MHz, CDCl3, 
COSY, g-HSQC) 1.39-1.46 (m, 2H, H-3), 1.54-1.61 (m, 1H, H-2), 1.66 (br.s, 3H, OH, NH), 1.76-1.80 
(m, 1H, H-2), 2.65-2.72 (m, 2H, H-4, H-5), 2.78-2.82 (m, 1H, H-5), 3.44 (dd, J = 10.2, 8.5 Hz, 1H, 
CH2O), 3.56 (t, J = 6.4 Hz, 2H, H-1), 3.60-3.68 (m, 2H, CH2O, CHN), 7.13-7.34 (m, 10H, ArH); 
13
C 
NMR (100.6 MHz, CDCl3) 30.1 (C-2), 30.5 (C-3), 46.0 (C-4), 53.3 (C-5), 62.7 (C-1), 64.8 (CHN), 
66.4 (CH2O), 126.5, 126.9 (C-p), 127.2, 127.7, 128.6, 128.6 (C-o, C-m), 140.4, 143.4 (C-i); HRMS 
(ESI-TOF) m/z: [M + H]
+
 Calcd for C19H26NO2 300.1958; Found 300.1952. 
(R)-4-Benzyl-5-{[(1R)-2-hydroxy-1-phenylethyl]amino}-1-pentanol (7e): Operating as described for 
the preparation of 7a, from lactam 2e (324 mg, 1.05 mmol), n-BuLi (2.83 mL of a 2.5 M solution in 
hexanes, 4.53 mmol), and NH3
.
BH3 (140 mg, 4.53 mmol) in anhydrous THF (4 mL), aminoalcohol 7e 
 19 
(233 mg, 70 %) was obtained as a colorless oil after flash chromatography: []22D – 35.8 (c 1.15, 
MeOH); IR (film) 3331 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 1.23-1.40 (m, 1H, H-3), 
1.44-1.59 (m, 3H, H-3, H-2), 1.84 (br.s, 1H, H-4), 2.35-2.47 (m, 2H, H-5), 2.48-2.63 (m, 2H, CH2Ar), 
2.92 (br.s, 3H, OH, NH), 3.50-3.63 (m, 3H, H-1, CH2O), 3.64-3.73 (m, 2H, CH2O, CHN), 7.05-7.33 (m, 
10H, ArH); 
13
C NMR (100.6 MHz, CDCl3) 27.8 (C-3), 29.3 (C-2), 39.2 (CH2Ar), 39.6 (C-4), 50.1 (C-
5), 62.4 (C-1), 64.8 (CHN), 66.5 (CH2O), 125.8 (C-p), 127.3 (C-m), 127.6 (C-p), 128.2 (C-m), 128.5, 
128.9 (C-o), 140.1, 140.5 (C-i); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C20H28NO2 314.2115; 
Found 314.2111. 
(S)-5-[(tert-Butoxycarbonyl)amino]-4-methyl-1-pentanol (8a): A solution of aminodiol 7a (1.4 g, 5.9 
mmol) in anhydrous MeOH (35 mL) containing 45 % Pd(OH)2 (630 mg) was hydrogenated at 75 °C for 
22 h under 5 bar of pressure. Then, di-tert-butyl dicarbonate (1.55 g, 7.08 mmol) was added, and the 
mixture was stirred at room temperature for 24 h. The catalyst was removed by filtration and washed 
with hot MeOH. The combined organic solutions were concentrated to give an oil. Flash 
chromatography (8:2 hexane-EtOAc) afforded pure alcohol 8a (893 mg, 70 %) as a colorless oil: []22D 
– 2.89 (c 1.0, MeOH); IR (film) 3355, 1692 cm-1; 1H NMR (400 MHz, CDCl3, COSY, g-HSQC) 0.90 
(d, J = 6.8 Hz, 3H, CH3), 1.05-1.18 (m, 1H, H-3), 1.30-1.40 (m, 1H, H-3), 1.38 [s, 9H, (CH3)3], 1.45-
1.57 (m, 3H, H-2, H-4), 2.60 (br.s, 1H, OH), 2.88 (ddd, J = 13.2, 6.4, 6.4 Hz, 1H, H-5), 2.99 (ddd, J = 
13.2, 6.4, 6.4 Hz, 1H, H-5), 3.55 (t, J = 6.4 Hz, 2H, H-1), 4.77 (br.s, 1H, NH); 
13
C NMR (100.6 MHz, 
CDCl3) 17.4 (CH3), 28.3 [C(CH3)3], 29.8 (C-3), 30.1 (C-2), 33.4 (C-4), 46.3 (C-5), 62.6 (C-1), 79.1 
[C(CH3)3], 156.3 (CO); HRMS (ESI-TOF) m/z: [M – Boc + 2H]
+
 Calcd for C6H16NO 118.1226; Found 
118.1227. 
(S)-5-[(tert-Butoxycarbonyl)amino]-4-ethyl-1-pentanol (8b): Operating as above, from a solution of 
aminodiol 7b (325 mg, 1.29 mmol) in anhydrous MeOH (10 mL), 45 % Pd(OH)2 (146 mg), and Boc2O 
(339 mg, 1.55 mmol), alcohol 8b (195 mg, 65 %) was obtained as a colorless oil after column 
chromatography (from hexane-EtOAc 7:3 to hexane-EtOAc 1:1): []22D – 3.3 (c 0.84, MeOH); IR (film) 
3348, 1692 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 0.89 (t, J = 7.4 Hz, 3H, CH3), 1.24-
 20 
1.37 (m, 5H, CH3CH2, H-2, H-4), 1.44 [s, 9H, (CH3)3], 1.56-1.63 (m, 2H, H-3), 2.21 (br.s, 1H, OH), 
3.03-3.15 (m, 2H, H-5), 3.64 (t, J = 6.3 Hz, 2H, H-1), 4.54 (br.s, 1H, NH); 
13
C NMR (100.6 MHz, 
CDCl3) 10.9 (CH3), 24.1 (CH3CH2), 26.9 (C-2), 28.4 [(CH3)3], 29.5 (C-3), 39.6 (C-4), 43.0 (C-5), 62.9 
(C-1), 79.0 [C(CH3)3], 156.3 (NCO); HRMS (ESI-TOF) m/z: [M – tBu + 2H]
+
 Calcd for C8H18NO3 
176.1281; Found 176.1279. 
(R)-5-[(tert-Butoxycarbonyl)amino]-4-isopropyl-1-pentanol (8c): Operating as described for the 
preparation of 8a, from a solution of 7c (500 mg, 1.88 mmol) in anhydrous MeOH (12 mL), 45 % 
Pd(OH)2 (225 mg), and Boc2O (493 mg, 1.2 mmol), alcohol 8c (208 mg, 45 %) was obtained after 
column chromatography (from hexane-EtOAc 8:2 to EtOAc): []22D + 2.5 (c 1.25, MeOH); IR (film) 
3347, 1693 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 0.89 (d, J = 6.9 Hz, 6H, 2CH3), 1.24-
1.33 (m, 3H, H-2, H-4), 1.44 [s, 9H, (CH3)3], 1.59-1.63 (m, 2H, H-3), 1.67-1.74 [m, 1H, CH(CH3)2], 
3.06-3.17 (m, 2H, H-5), 3.64 (t, J = 6.4 Hz, 2H, H-1), 4.52 (br.s, 1H, NH); 
13
C NMR (100.6 MHz, 
CDCl3) 19.2 (CH3), 19.5 (CH3), 24.6 (C-3), 28.4 [CH(CH3)2, (CH3)3], 30.5 (C-2), 41.4 (C-5), 44.3 (C-
4), 62.9 (C-1), 79.1 [C(CH3)3], 156.2 (NCO); HRMS (ESI-TOF) m/z: [M – tBu + 2H]
+
 Calcd for 
C9H20NO3 190.1438; Found 190.1438. 
(R)-5-[(tert-Butoxycarbonyl)amino]-4-phenyl-1-pentanol (8d): Operating as described for the 
preparation of 8a, from a solution of 7d (193 mg, 0.65 mmol) in anhydrous MeOH (16 mL), 45 % 
Pd(OH)2 (86 mg), and Boc2O (169 mg, 0.77 mmol), alcohol 8d (97 mg, 53 %) was obtained after 
column chromatography (from hexane-EtOAc 8:2 to hexane-EtOAc 1:1): []22D + 10.9 (c 0.65, MeOH); 
IR (film) 3363, 1693 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 1.40 [s, 9H, (CH3)3], 1.43-
1.49 (m, 2H, H-2), 1.57-1.67 (m, 1H, H-3), 1.73-1.80 (m, 1H, H-3), 2.76 (br.s, 1H, H-4), 3.18 (ddd, J = 
13.6, 8.7, 4.9 Hz, 1H, H-5), 3.47-3.42 (m, 1H, H-5), 3.57 (t, J = 6.4 Hz, 2H, H-1), 4.43 (br.s, 1H, NH), 
7.15-7.17 (m, 2H, ArH), 7.21-7.27 (m, 1H, H-p), 7.30-7.34 (m, 2H, ArH); 
13
C NMR (100.6 MHz, 
CDCl3) 28.3 [(CH3)3], 29.6 (C-3), 30.4 (C-2), 45.9 (C-4), 46.2 (C-5), 62.6 (C-1), 79.2 [C(CH3)3], 
126.7 (C-p), 127.8, 128.6 (C-o, C-m), 142.6 (C-i), 156.0 (NCO); HRMS (ESI-TOF) m/z: [M + H]
+
 
Calcd for C16H26 NO3 280.1907; Found 280.1905. 
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(R)-4-Benzyl-5-[(tert-butoxycarbonyl)amino]-1-pentanol (8e): Operating as described for the 
preparation of 8a, from a solution of 7e (260 mg, 0.83 mmol) in anhydrous MeOH (10 mL), 45 % 
Pd(OH)2 (117 mg), and Boc2O (217 mg, 1.0 mmol), alcohol 8e (123 mg, 51 %) was obtained as a 
colorless oil after column chromatography (from hexane-EtOAc 8:2 to EtOAc): []22D – 1.87 (c 0.8, 
MeOH); IR (film) 3348, 1689 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 1.33-1.39 (m, 2H, 
H-3), 1.43 [s, 9H, (CH3)3], 1.54-1.68 (m, 2H, H-2), 1.82-1.86 (m, 1H, H-4), 2.04 (br.s., 1H, OH), 2.57 
(d, J = 7.2 Hz, 2H, CH2Ar), 3.09 (t, J = 5.6 Hz, 2H, H-5), 3.58 (t, J = 6.3 Hz, 2H, H-1), 4.62 (br.s, 1H, 
NH), 7.14-7.20 (m, 3H, ArH), 7.25-7.29 (m, 2H, ArH); 
13
C NMR (100.6 MHz, CDCl3) 27.2 (C-3), 
28.3 [(CH3)3], 29.5 (C-2), 38.6 (CH2Ar), 40.4 (C-4), 43.2 (C-5), 62.7 (C-1), 79.2 [C(CH3)3], 126.0 (C-
p), 128.3, 129.0 (C-o, C-m), 140.3 (C-i), 156.3 (NCO); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for 
C17H28NO3 294.2064; Found 294.2063. 
(S)-4-Methyl-5-[(2-nitrobenzenesulfonyl)amino]-1-pentanol (9a): A solution of aminodiol 7a (1.36 
g, 5.73 mmol) in anhydrous MeOH (35 mL) containing 20 % Pd(OH)2 (272 mg) was hydrogenated at 68 
°C for 18 h under 10 bar of pressure. The catalyst was removed by filtration and washed with hot 
MeOH. The combined organic solutions were concentrated, and the resulting residue was dissolved in 
CH2Cl2 (19 mL). 2-Nitrobenzenesulfonyl chloride (1.4 g, 6.3 mmol) and Et3N (0.88 mL, 6.3 mmol) 
were added, and the mixture was allowed to react at room temperature for 18 h. The solvent was 
removed under reduced pressure, and the residue was chromatographed (from 7:3 hexane-EtOAc to 
EtOAc) to give alcohol 9a (1.25 g, 72 %) as a colorless oil: []22D + 2.66 (c 1.05, MeOH); IR (film) 
3349 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 0.93 (d, J = 6.4 Hz, 3H, CH3), 1.22-1.28 
(m, 1H, H-3), 1.42-1.54 (m, 3H, H-3, H-2, OH), 1.55-1.62 ( m, 1H, H-2), 1.64-1.74 (m, 1H, H-4), 2.92 
(ddd, J = 13.2, 6.8, 6.8 Hz, 1H, H-5), 3.01 (ddd, J = 13.2, 6.8, 6.8 Hz, 1H, H-5), 3.61 (t, J = 6.4 Hz, 2H, 
H-1), 5.35 (t, J = 6.2 Hz, 1H, NH), 7.73-7.75 (m, 2H, H-5Ns, H-6Ns), 7.85 (m, 1H, H-4Ns), 8.12 (m, 
1H, H-3Ns); 
13
C NMR (100.6 MHz, CDCl3) 17.4 (CH3), 29.6 (C-2), 29.9 (C-3), 33.1 (C-4), 49.5 (C-
5), 62.8 (C-1), 125.3, 131.1 (C-3Ns, C-6Ns), 132.7 (C-4Ns), 133.5 (C-1Ns), 133.7 (C-5Ns), 148.1 (C-
2Ns); HRMS (ESI-TOF) m/z: [M + H] Calcd for C12H19N2O5S 303.1009; Found 303.1008. 
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(S)-4-Ethyl-5-[(2-nitrobenzenesulfonyl)amino]-1-pentanol (9b): Operating as above, from a solution 
of 7b (1.15 g, 4.56 mmol) in anhydrous MeOH (25 mL), 20 % Pd(OH)2 (230 mg), 2-
nitrobenzenesulfonyl chloride (1.12 g, 5.0 mmol), and Et3N (0.7 mL, 5.0 mmol) in CH2Cl2 (16 mL), 
alcohol 9b (1.09 g, 76 %) was obtained as a colorless oil after column chromatography (from 7:3 
hexane-EtOAc to EtOAc): []22D + 0.95 (c 0.84, MeOH); IR (film) 3348 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3, COSY, g-HSQC) 0.84 (t, J = 7.6 Hz, 3H, CH3), 1.30-1.40 (m, 4H, H-3, CH3CH2), 1.47-1.54 
(m, 3H, H-2, H-4), 1.65 (br.s, 1H, OH), 3.02 (dt, J = 6.1, 3.7 Hz, 2H, H-5), 3.60 (t, J = 6.4 Hz, 2H, H-1), 
5.41 (t, J = 6.0 Hz, 1H, NH), 7.76 (m, 2H, H-5Ns, H-6Ns), 7.85 (m, 1H, H-4Ns), 8.13 (m, 1H, H-3Ns); 
13
C NMR (100.6 MHz, CDCl3) 10.7 (CH3), 23.9 (CH3CH2), 26.9 (C-3), 29.3 (C-2), 33.1 (C-4), 46.2 
(C-5), 62.8 (C-1), 125.3, 131.1 (C-3 Ns, C-6Ns), 132.7 (C-4Ns), 133.5 (C-1Ns), 133.6 (C-5Ns), 148.0 
(C-2Ns); HRMS (ESI-TOF) m/z: [M + H] Calcd for C13H21N2O5S 317.1166; Found 317.1161. 
(S)-4-Methyl-5-[(p-methylbenzenesulfonyl)amino]-1-pentanol (10a): A solution of aminodiol 7a (1.5 
g, 6.32 mmol) in anhydrous MeOH (110 mL) containing 20 % Pd(OH)2 (300 mg) was hydrogenated at 
68 °C for 19 h under 11 bar of pressure. The catalyst was removed by filtration and washed with hot 
MeOH, and the combined organic solutions were concentrated. The resulting residue was dissolved in 
CHCl3 (30 mL), and p-toluenesulfonyl chloride (1.33 g, 6.96 mmol) and Et3N (1.06 mL, 7.56 mmol) 
were added. The mixture was allowed to react at room temperature for 15 h. The solvent was evaporated 
under reduced pressure, and the residue was chromatographed (from 9:1 hexane-EtOAc to EtOAc) to 
give alcohol 10a (1.01 g, 59 %) as a yellow oil: []22D + 0.61 (c 0.8, MeOH);  IR  (film)  3507, 3286 
cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 0.86 (d, J = 6.8 Hz, 3H, CH3), 1.09-1.16 (m, 1H, 
H-3), 1.38-1.48 (m, 1H, H-3), 1.50-1.64 (m, 3H, H-2, H-4), 2.42 (s, 3H, CH3Ts), 2.74 (dd, J = 12.5, 6.4 
Hz, 1H, H-5), 2.79 (dd, J = 12.5, 6.8 Hz, 1H, H-5), 3.57 (t, J = 6.1 Hz, 2H, H-1), 5.32 (br.s, 1H, NH), 
7.24 (d, J = 8.3 Hz, 2H, H-3 Ts, H-5 Ts), 7.74 (d, J = 8.3 Hz, 2H, H-2 Ts, H-6 Ts); 
13
C NMR (100.6 
MHz, CDCl3) 17.4 (CH3), 21.4 (CH3Ts), 29.4 (C-3), 29.7 (C-2), 32.8 (C-4), 48.7 (C-5), 62.6 (C-1), 
126.9 and 129.6 (CHTs), 136.9 (C-4Ts), 143.2 (C-1Ts); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for 
C13H22NO3S 272.1315; Found 272.1317. 
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(S)-4-Methyl-5-[N-(2-nitrobenzenesulfonyl)-10-undecenylamino]-1-pentanol (11): 11-Bromo-1-
undecene (0.10 mL, 0.44 mmol) was added to a suspension of alcohol 9a (110 mg, 0.36 mmol) and 
Cs2CO3 (154 mg, 0.47 mmol) in anhydrous DMF (2.5 mL), and the resulting mixture was stirred at 55 
ºC for 3 h. The mixture was cooled to room temperature, poured into brine, and extracted with Et2O. 
The combined organic extracts were dried, filtered, and concentrated to give an oil. Flash 
chromatography (7:3 hexane-EtOAc) afforded alkene 11 (130 mg, 79 %) as a colorless oil: []22D – 10.2 
(c 1.25, MeOH); IR (film) 3334 cm
-
1; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC 0.87 (d, J = 6.6 
Hz, 3H, CH3), 1.05-1.13 (m, 1H, H-3), 1.15-1.29 (m, 9H, H-3, 4CH2), 1.32-1.38 (m, 2H, CH2), 1.40-
1.52 (m, 5H, CH2), 1.58-1.67 (m, 1H, CH2), 1.71-1.80 (m, 1H, H-4), 1.99-2.05 (m, 2H, CH2=CHCH2), 
3.12 (dd, J = 14.2, 8.1 Hz, 1H, H-5), 3.20 (dd, J = 14.2, 7.1 Hz 1H, H-5), 3.18-3.32 (m, 2H, CH2N), 3.61 
(t, J = 6.4 Hz, 2H, H-1), 4.91-5.02 (m, 2H, CH2=CH), 5.81 (qt, J = 17.0, 10.2, 6.7, 6.7 Hz, 1H, 
CH2=CH), 7.60-7.70 (m, 3H, H-3Ns, H-5Ns, H-6Ns), 7.99-8.02 (m, 1H, H-4Ns); 
13
C NMR (100.6 
MHz, CDCl3) 17.0 (CH3), 26.6 (CH2), 27.6 (CH2), 28.9 (CH2), 29.0 (CH2), 29.1 (CH2), 29.3 (CH2), 
29.4 (CH2), 29.9 (CH2), 29.9 (CH2), 31.0 (C-4), 33.7 (CH2=CHCH2), 47.2 (CH2N), 53.2 (C-5), 62.9 (C-
1), 114.1 (CH2=CH), 124.1 and 130.9 (C-3Ns, C-6Ns), 131.4 (C-4Ns), 133.2 (C-1Ns), 133.8 (C-5Ns), 
139.1 (CH2=CH), 148.0 (C-2Ns); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C23H39N2O5S 455.2574; 
Found 455.2570. 
N-[2-Methyl-5-hexenyl)-N-(2-nitrobenzenesulfonyl)-10-undecenamine (12): Dess–Martin reagent 
(168 mg, 0.40 mmol) was added to a solution of alcohol 11 (90 mg, 0.20 mmol) in anhydrous CH2Cl2 
(1.5 mL), and the mixture was stirred at room temperature for 1.5 h. Then, saturated aqueous Na2S2O4 
(0.75 mL) and saturated aqueous NaHCO3 (0.75 mL) were added, and the resulting mixture was stirred 
for 1 h. The aqueous layer was extracted with CH2Cl2, and the combined organic extracts were washed 
with brine, dried, filtered, and concentrated to give an aldehyde, which was used without purification in 
the next step: 
1
H NMR (300 MHz, CDCl3 0.88 (d, J = 8.8 Hz, 3H, CH3), 1.12-1.29 (m, 9H), 1.31-
1.51 (m, 6H), 1.73-1.84 (m, 2H), 1.99-2.07 (m, 2H, CH2=CHCH2), 2.37-2.58 (m, 2H, CH2COH), 3.10-
3.28 (m, 4H, 2CH2N), 4.91-5.02 (m, 2H, CH2=CH), 5.80 (qt, J = 16.9, 10.1, 6.7, 6.7 Hz, 1H, CH2=CH), 
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7.60-7.70 (m, 3H, H-Ns), 7.99-8.02 (m, 1H, H-Ns), 9.76 (s, 1H, COH). t-BuOK (0.99 mL of a 1 M 
solution in THF, 0.99 mmol) was added to a solution of methyltriphenylphosphonium bromide (497 mg, 
1.38 mmol) in THF (10 mL) at room temperature, and the mixture was stirred for 1 h. Then, a solution 
of the above aldehyde in THF (10 mL) was added via cannula, and the resulting mixture was stirred at 
room temperature for 3 h. Saturated aqueous NH4Cl was added, and the resulting mixture was extracted 
with EtOAc. The extracts were dried, filtered, and concentrated. The residue was chromatographed (9:1 
hexane-EtOAc) to give diene 12 (55 mg, 61 %) as a colorless oil: []22D – 3.58 (c 0.9, MeOH); 
1
H NMR 
(400 MHz, CDCl3, COSY, g-HSQC)  0.85 (d, J = 6.6 Hz, 3H, CH3), 1.09-1.30 (m, 11H, CH2), 1.32-
1.33 (m, 2H, CH2), 1.41-1.50 (m, 3H, CH2), 1.70-1.75 (m, 1H, CH), 1.95-2.06 (m, 3H, CH2), 2.08-2.17 
(m, 1H, CH2), 3.12 (dd, J = 14.2, 8.3 Hz, 1H, CH2N), 3.18 (dd, J = 14.2, 8.8 Hz, 1H, CH2N), 3.13-3.21 
(m, 2H, CH2N), 4.91-5.02 (m, 4H, CH2=CHCH2), 5.74 (qt, J = 17.0, 10.1, 10.1, 6.7 Hz, 1H, CH2=CH), 
5.80 (qt, J = 17.3, 10.3, 10.3, 7.0 Hz, 1H, CH2=CH), 7.59-7.62 (m, 1H, H-3Ns), 7.63-7.70 (m, 2H, H-
5Ns, H-6Ns), 7.99-8.03 (m, 1H, H-4Ns); 
13
C NMR (100.6 MHz, CDCl3) 17.0 (CH3), 26.6 (CH2), 27.6 
(CH2), 28.9 (CH2), 29.0 (CH2), 29.1 (CH2), 29.3 (CH2), 29.4 (CH2), 30.4 (CH), 31.1 (CH2), 33.0 
(CH2=CHCH2), 33.8 (CH2=CHCH2), 47.1 (C-1), 53.1 (CH2N), 114.1 (CH2=CH), 114.7 (CH2=CH), 
124.1 (C-3Ns), 130.9 (C-6Ns), 131.4 (C-4Ns), 133.2 (C-5Ns), 133.9 (C-1Ns), 138.4 (CH2=CH), 139.1 
(CH2=CH), 148.0 (C-2Ns); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C24H39N2O4S 451.2625; Found 
451.2622. 
(S)-3-Methyl-1-(2-nitrobenzenesulfonyl)azacyclohexadec-6-ene (13): A solution of 12 (58 mg, 0.13 
mmol) in anhydrous CH2Cl2 (10 mL) was added to a solution of second-generation Grubbs catalyst 
(16.4 mg, 0.02 mmol) in CH2Cl2 (650 mL) at reflux. The resulting mixture was stirred at reflux 
temperature for 14 h. The solvent was evaporated, and the resulting residue was chromatographed (95:5 
hexane-EtOAc) to yield a 86:14 (calculated by GC/MS) mixture of E/Z diastereoisomers 13 (44 mg, 80 
%). Major diastereoisomer: 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 0.84 (d, J = 6.6 Hz, 3H, 
CH3), 1.06-1.18 (m, 1H, H-4), 1.19-1.59 (m, 15H, H-4, 7CH2), 1.78-1.87 (m, 1H, H-3), 1.97-2.10 (m, 
3H, H-5, H-8), 2.12-2.18 (m, 1H, H-8), 3.08 (dd, J = 13.9, 6.7 Hz, 1H, H-2), 3.14-3.24 (m, 3H, H-2, H-
 25 
16), 5.26-5.45 (m, 2H, H-6, H-7), 7.59-7.62 (m, 1H, H-3Ns), 7.64-7.69 (m, 2H, H-5Ns, H-6Ns), 7.97-
8.02 (m, 1H, H-4Ns); 
13
C NMR (100.6 MHz, CDCl3) 15.9 (CH3), 24.4 (CH2), 25.7 (CH2), 26.2 (CH2), 
26.3 (CH2), 26.8 (CH2), 27.0 (CH2), 27.4 (CH2), 28.1 (C-3), 28.9 (CH2CH=), 30.9 (CH2CH=), 33.3 (C-
4), 46.5 (C-16), 54.1 (C-2), 124.0 (C-3Ns), 130.0 (CH=), 130.8 (C-6Ns), 131.3 (CH=), 131.4 (C-4Ns), 
133.1 (C-5Ns), 133.6 (C-1Ns), 148.1 (C-2Ns); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for 
C22H35N2O4S 423.2312; Found 423.2301.  
(S)-3-Methylazacyclohexadec-6-ene (14): K2CO3 (194 mg, 1.41 mmol) and thiophenol (0.058 mL, 
0.56 mmol) were added to a solution of 13 (198 mg, 0.47 mmol) in anhydrous DMF (9 mL), and the 
mixture was stirred at room temperature for 14 h. The reaction was quenched by the addition of aqueous 
2 M NaOH, and the resulting mixture was extracted with CH2Cl2. The combined organic extracts were 
dried, filtered, and evaporated. The resulting residue was chromatographed (from 95:5 hexane-EtOAc to 
8:2 EtOAc-Et3N) to afford compound 14 (64 mg, 58 %) as a 84:16 (calculated by GC/MS) mixture of 
E/Z diastereoisomers as a brown oil. Major diastereoisomer: 
1
H NMR (400 MHz, CDCl3, COSY, g-
HSQC) 0.87 (d, J = 6.6 Hz, 3H, CH3), 1.14-1.22 (m, 1H, H-4), 1.24-1.54 (m, 15H, H-4, 7CH2), 1.68-
1.77 (m, 1H, H-3), 1.95-2.16 (m, 4H, H-5, H-8), 2.46 (m, 2H, H-2), 2.48-2.58 (m, 1H, H-16), 2.62-2.72 
(m, 1H, H-16), 5.35-5.40 (m, 2H, H-6, H-7); 
13
C NMR (100.6 MHz, CDCl3) 17.8 (CH3), 25.0 (CH2), 
26.0 (CH2), 26.5 (CH2), 27.3 (CH2), 27.3 (CH2), 27.6 (CH2), 28.3 (CH2), 29.2 (CH2), 30.1 (C-3), 31.9 
(CH2CH=), 34.0 (CH2CH=), 47.0 (C-16), 55.4 (C-2), 130.7 (CH=), 130.9 (CH=); HRMS (ESI-TOF) 
m/z: [M + H]
+
 Calcd for C16H32N 238.2529; Found 238.2523.  
Haliclorensin C: A solution of alkene 14 (46 mg, 0.19 mmol) in anhydrous MeOH (10 mL) containing 
25% Pd/C (12 mg) was hydrogenated at room temperature for 14 h under 10 bar of pressure. The 
catalyst was removed by filtration and washed with hot MeOH, and the combined organic solutions 
were concentrated. Flash chromatography (from 95:5 hexane-EtOAc to 8:2 EtOAc-Et3N) of the residue 
gave haliclorensin C (15a, 33 mg, 71 %) as a brown oil: []22D – 6.04 (c 0.85, MeOH), lit
13
 []20D + 53 
(c 0.15, MeOH). 
1
H NMR [500 MHz, 4:1 CDCl3-CD3OD, COSY, g-HSQC; see Table 1 in Supporting 
Information]  0.73 (d, J = 6.8 Hz, 3H, CH3), 1.08-1.22 (m, 1H, H-4), 1.30-1.41 (m, 20H, 10CH2), 1.42-
 26 
1.56 (m, 3H, H-4, CH2), 1.60-1.63 (m, 1H, H-3), 2.30 (dd, J = 11.8, 7.7 Hz, 1H, H-2), 2.36 (dd, J = 
11.8, 5.2 Hz, 1H, H-2), 2.48-2.54 (m, 1H, H-16), 2.64-2.70 (m, 1H, H-16); 
13
C NMR [125 MHz, 4:1 
CDCl3-CD3OD; see Table 2 in Supporting Information] 18.2 (CH3), 24.2 (CH2), 24.9 (CH2), 26.0 
(CH2), 26.1 (2CH2), 26.2 (CH2), 26.3 (CH2), 26.4 (CH2), 26.5 (CH2), 27.0 (2CH2), 30.7 (C-3), 32.4 (C-
4), 47.0 (C-16), 53.8 (C-2); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C16H34N 240.2686; Found 
240.2681. Haliclorensin C hydrochloride: 
1
H NMR [400 MHz, 4:1 CDCl3-CD3OD, COSY, g-HSQC; 
see Table 1 in Supporting Information]  1.06 (d, J = 6.8 Hz, 3H, CH3), 1.26-1.40 (m, 22H, 11CH2), 
1.75 (m, 2H, H-15), 1.89 (m, 1H, H-3), 2.78-2.84 (m, 2H, H-2), 2.89-2.99 (m, 2H, H-16); 
13
C NMR 
[100.6 MHz, 4:1 CDCl3-CD3OD; see Table 2 in Supporting Information] 17.9 (CH3), 23.7 (C-15), 
24.7 (CH2), 24.9 (CH2), 26.2 (CH2), 26.3 (CH2), 26.4 (CH2), 26.5 (CH2), 26.6 (CH2), 26.7 (CH2), 26.8 
(CH2), 27.1 (CH2), 28.7 (C-3), 32.6 (C-4), 45.6 (C-16), 50.9 (C-2). 
(S)-4-Methyl-5-[N-(2-nitrobenzenesulfonyl)-4-pentenylamino]-1-pentanol (15): Operating as 
described for the preparation of alcohol 11, from 9a (1.15 g, 3.80 mmol), Cs2CO3 (1.61 g, 4.95 mmol), 
and 5-bromo-1-pentene (0.54 mL, 4.56 mmol) in anhydrous DMF (25 mL), compound 15 (1.06 g, 75 
%) was obtained as a yellow oil after flash chromatography (from 7:3 hexane-EtOAc to 1:1 hexane-
EtOAc): []22D – 13.4 (c 1.85, MeOH); 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 0.86 (d, J = 6.7 
Hz, 3H, CH3), 1.05-1.14 (m, 1H, H-3), 1.40-1.52 (m, 2H, H-2, H-3), 1.55-1.66 (m, 4H, H-2, CH2, OH), 
1.71-1.80 (m, 1H, H-4), 1.95-2.00 (m, 2H, CH2=CHCH2), 3.11 (dd, J = 14.2, 8.1 Hz, 1H, H-5), 3.20 (dd, 
J = 14.2, 7.1 Hz, 1H, H-5), 3.19-3.33 (m, 2H, CH2N), 3.59 (t, J = 6.4 Hz, 2H, H-1), 4.93-4.99 (m, 2H, 
CH2=CH), 5.69 (qt, J = 16.9, 10.2, 10.2, 6.6, Hz, 1H, CH2=CH), 7.59-7.63 (H-3Ns), 7.64-7.71 (m, 2H, 
H-5Ns, H-6Ns), 7.97-8.02 (m, 1H, H-4Ns); 
13
C NMR (100.6 MHz, CDCl3) 17.0 (CH3), 26.8 (CH2), 
29.8 (CH2), 29.9 (CH2), 30.6 (CH2=CHCH2), 31.1 (C-4), 46.8 (CH2N), 53.5 (C-5), 62.9 (C-1), 115.4 
(CH2=CH), 124.1 (C-3Ns), 130.9 (C-6Ns), 131.5 (C-4Ns), 133.3 (C-5Ns), 133.6 (C-1Ns), 137.1 
(CH2=CH), 147.9 (C-2Ns); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C17H27N2O5S 371.1635; Found 
371.1635. 
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(S)-2-Methyl-N-(2-nitrobenzenesulfonyl)-N-(4-pentenyl)-5-hexenamine (16): Operating as described 
for the preparation of 12, from alcohol 15 (355 mg, 1.0 mmol) and Dess–Martin reagent (1.49 g, 3.52 
mmol) in anhydrous CH2Cl2 (9 mL), an aldehyde was obtained: 
1
H NMR (300 MHz, CDCl3 0.88 (d, 
J = 6.6 Hz, 3H, CH3), 1.33-1.39 (m, 1H), 1.53-1.63 (m, 2H), 1.74-1.83 (m, 2H), 1.95-2.02 (m, 2H), 
2.40-2.52 (m, 2H, CH2COH), 3.11-3.30 (m, 4H, 2CH2N), 4.94-5.00 (m, 2H, CH2=CH), 5.64-5.75 (m, 
1H, CH2=CH), 7.50-7.60 (m, 3H, H-Ns), 7.99-8.00 (m, 1H, H-Ns), 9.75 (s, 1H, COH). Then, from the 
above aldehyde, t-BuOK (5.9 mL of a 1 M solution in THF, 5.9 mmol), and 
methyltriphenylphosphonium bromide (2.94 g, 8.22 mmol) in anhydrous THF (60 mL), diene 16
14c
 (175 
mg, 50 %) was obtained as a colorless oil after flash chromatography (9:1 hexane-EtOAc): []22D  – 
12.0 (c 1.3, CHCl3), lit
14c
 []22D – 15.0 (c 1.3, CHCl3); 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC)  
0.85 (d, J = 6.6 Hz, 3H, CH3), 1.09-1.18 (m, 1H), 1.41-1.50 (m, 1H), 1.53-1.65 (m, 2H), 1.70-1.79 (m, 
1H), 1.95-2.02 (m, 3H, CH2=CHCH2, CH2), 2.07-2.17 (m, 1H, CH2=CHCH2), 3.13 (dd, J= 14.2, 8.3 Hz, 
2H, C-1), 3.19 (dd, J= 14.2, 7.2 Hz, 2H, C-1), 3.26 (m, 2H, CH2N), 4.92-4.97 (m, 3H, CH2=CHCH2), 
4.99-5.01 (m, 1H, CH2=CHCH2), 5.65-5.72 (m, 1H, CH2=CH), 5.72-5.79 (m, 1H, CH2=CH), 7.59-7.62 
(m, 1H, H-3Ns), 7.65-7.68 (m, 2H, H-5Ns, H-4Ns), 7.99-8.02 (m, 1H, H-4Ns); 
13
C NMR (100.6 MHz, 
CDCl3) 16.9 (CH3), 26.8 (CH2), 30.4 (CH), 30.7 (CH2), 30.9 (CH2), 33.0 (CH2), 46.7 (CH2), 53.4 
(CH2), 114.7 (CH2=CH), 115.4 (CH2=CH), 124.1 (C-3Ns), 130.9 (C-6Ns), 131.4 (C-4Ns), 133.3 (C-
5Ns), 133.7 (C-1Ns), 137.1 (CH2=CH), 138.3 (CH2=CH), 147.9 (C-2Ns). 
(S)-5-[(tert-Butyldimethylsilyl)oxy]-2-methyl-N-tosylpentanamine (17): tert-Butyldimethylsilyl 
chloride (773 mg, 5.13 mmol) was added to a solution of alcohol 10a (870 mg, 3.20 mmol) and 
imidazole (349 mg, 5.13 mmol) in anhydrous CH2Cl2 (10 mL), and the mixture was heated at reflux for 
15 h. The reaction was quenched by a saturated aqueous solution of NH4Cl, and the mixture was 
extracted with CH2Cl2. The combined organic extracts were dried, filtered, and concentrated to give an 
oil (1.2 g). Purification by flash chromatography (from 9:1 hexane-EtOAc to 1: 1 hexane-EtOAc) 
afforded pure compound 17 (1.09 g, 88 %) as a colorless oil: []22D = – 0.19 (c 1.02, MeOH); IR (film) 
3564, 3282 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC)  – 0.01 (s, 6H, CH3Si), 0.84 [s, 9H, 
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(CH3)3], 0.86 (d, J = 6.0 Hz, 3H, CH3), 1.07-1.09 (m, 1H, H-3), 1.28-1.45 (m, 3H, H-4, H-3), 1.52-1.59 
(m, 1H, H-2), 2.39 (s, 3H, CH3Ts), 2.69 (ddd, J = 12.5, 6.8, 6.8 Hz, 1H, H-1), 2.79 (ddd, J = 12.5, 5.6, 
5.6 Hz, 1H, H-1), 3.50 (dt, J = 6.4, 1.5 Hz, 2H, H-5), 5.18 (br.s, 1H, NH), 7.26 (d, J = 8.4 Hz, 2H, H-
3Ts, H-5Ts), 7.73 (d, J = 8.4 Hz, 2H, H-2Ts, H-6Ts); 
13
C NMR (100.6 MHz, CDCl3) – 5.4 (CH3Si), 
17.4 (CH3), 18.2 [C(CH3)3], 21.3 (CH3Ts), 25.8 [C(CH3)3], 29.8 (C-3), 30.0 (C-4), 32.8 (C-2), 48.8 (C-
1), 63.1 (C-5), 126.9 (C-HTs), 129.5 (C- HTs), 137.0 (C-4Ts), 143.0 (C-1Ts); HRMS (ESI-TOF) m/z: 
[M + H]
+
 Calcd for C19H36NO3SSi 386.2180; Found 386.2179. 
(S)-5-[(tert-Butyldimethylsilyl)oxy]-2-methyl-N-[3-(phthalimido)propyl]-N-tosylpentanamine (18): 
NaH (95 %, 136 mg, 5.39 mmol) was added to a solution of compound 17 (562 mg, 1.46 mmol) and 3-
(phthalimido)propyl iodide
18
 (964 mg, 3.06 mmol) in anhydrous DMF (9 mL), and the mixture was 
stirred at room temperature for 17 h. The reaction was quenched by addition of a saturated aqueous 
NH4Cl solution, and the aqueous layer was extracted with EtOAc. The combined organic extracts were 
dried, filtered, and concentrated. The resulting oil (1.03 g) was chromatographed (from 9:1 hexane-
EtOAc to 8: 2 hexane-EtOAc) to give compound 18 (630 g, 75 %) as a colorless oil: []22D – 4.61 (c 
1.65, MeOH); IR (film) 1773 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC)  0.04 (s, 6H, 
CH3Si), 0.88 [s, 9H, (CH3)3], 0.91 (d, J = 6.6 Hz, 3H, CH3), 1.03-1.12 (m, 1H), 1.36-1.50 (m, 2H), 1.55-
1.61 (m, 1H), 1.74 (m, 1H, H-4), 1.84-1.95 (m, 2H, CH2CH2N), 2.41 (s, 3H, CH3Ts), 2.91 (d, J = 7.5 
Hz, 2H, H-1), 3.12-3.17 (m, 2H, CH2NTs), 3.56 (t, J = 6.5 Hz, 2H, H-5), 3.66 (t, J = 7.1 Hz, 2H, 
CH2NPhth), 7.27 (d, J = 8.3 Hz, 2H, H-3Ts, H-5Ts), 7.64 (d, J = 8.3 Hz, 2H, H-2Ts, H-6Ts), 7.73 (dd, J 
= 5.4, 3.0 Hz, 2H, H-Phth), 7.84 (dd, J = 5.4, 3.0 Hz, 2H, H-Phth); 
13
C NMR (100.6 MHz, CDCl3) – 
5.3 (CH3Si), 17.3 (CH3), 18.2 [C(CH3)3], 21.5 (CH3Ts), 25.9 [C(CH3)3], 27.9 (CH2CH2N), 30.1 (C-3), 
30.3 (C-4), 31.9 (C-2), 35.6 (CH2NPhth), 46.7 (CH2NTs), 55.2 (C-1), 63.2 (C-5), 123.2 (CH-Phth), 
127.1 (C-HTs), 129.6 (C-HTs), 131.9 (C-Phth), 133.9 (CH-Phth), 136.4 (C-4Ts), 143.1 (C-1Ts), 168.1 
(CO); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C30H45N2O5SSi 573.2813; Found 573.2813. 
(S)-4-Methyl-5-{N-[3-(phthalimido)propyl]-N-tosylamino}-1-pentanol (19): A solution of compound 
18 (450 mg, 0.79 mol) in 1.0 N aqueous HCl (10 mL) was stirred at room temperature for 20 minutes. 
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Then, the solution was concentrated to give alcohol 19 (360 mg, quantitative), which was used in the 
next step without purification: []22D – 1.32 (c 1.12, MeOH); IR (film) 3542, 1770, 1716 cm
-1
; 
1
H NMR 
(400 MHz, CDCl3, COSY, g-HSQC) 0.90 (d, J = 6.6 Hz, 3H, CH3), 1.10-1.17 (m, 1H), 1.44-1.56 (m, 
2H), 1.60-1.66 (m, 1H), 1.66-1.78 (m, 2H, H-4, OH), 1.89 (quint, J = 7.4 Hz, 2H, CH2CH2N), 2.40 (s, 
3H, CH3Ts), 2.85 (dd, J = 13.6, 7.5 Hz, 1H, H-5), 2.95 (dd, J = 13.6, 7.5 Hz, 1H, H-5), 3.14 (m, 2H, 
CH2NTs), 3.62 (t, J = 6.2 Hz, 2H, H-1), 3.67 (t, J = 7.2 Hz, 2H, CH2NPhth), 7.27 (d, J = 8.2 Hz, 2H, H-
3Ts), 7.64 (d, J = 8.2 Hz, 2H, H-2Ts), 7.72 (m, 2H, H-Phth), 7.84 (m, 2H, H-Phth); 
13
C NMR (100.6 
MHz, CDCl3)  17.4 (CH3), 21.5 (CH3Ts), 27.9 (CH2CH2N), 29.8 (CH2), 30.1 (CH2), 31.9 (CH), 35.8 
(CH2NPhth), 46.9 (CH2NTs), 55.4 (C-5), 62.9 (C-1), 123.3 (CH-Phth), 127.2 (CHTs), 129.6 (CHTs), 
131.9 (C-Phth), 134.0 (CH-Phth), 136.2 (C-4Ts), 143.2 (C-1Ts), 168.2 (CO); HRMS (ESI-TOF) m/z: 
[M + H]
+
 Calcd for C24H31N2O5S 459.1948; Found 459.1941. 
(S)-2-Methyl-N-[3-(phthalimido)propyl]-N-tosyl-5-hexenamine (20): Operating as described for the 
preparation of compound 12, from alcohol 19 (95 mg, 0.21 mmol) and Dess–Martin reagent (220 mg, 
0.52 mmol) in anhydrous CH2Cl2 (2 mL), an aldehyde was obtained: 
1
H NMR (400 MHz, CDCl3 
0.91 (d, J = 6.8 Hz, 3H, CH3), 1.78-1.93 (m, 4H), 2.39-2.51 (m, 5H), 2.40 (s, 3H, CH3Ts), 2.87 (dd, 1H, 
J = 13.6, 7.6 Hz, CH2N), 2.98 (dd, J = 13.6, 7.2 Hz, 1H, CH2N), 3.13-3.19 (m, 2H, CH2N), 3.67 (t, J = 
6.8 Hz, 2H, CH2N), 7.27 (d, 2H, J = 8.2 Hz, H-Ts), 7.64 (d, J = 8.2 Hz, 2H, H-Ts), 7.75 (dd, J = 5.6, 3.2 
Hz, 2H, H-Phth), 7.80 (dd, J = 5.6, 3.2 Hz, 2H, H-Phth), 9.75 (s, 1H, COH). Then, from the above 
aldehyde (95 mg), t-BuOK (0.62 mL of a 1 M solution in THF, 0.62 mmol), and 
methyltriphenylphosphonium bromide (296 mg, 0.83 mmol) in anhydrous THF (5 mL), alkene 20 (66 
mg, 70 %) was obtained as a colorless oil after flash chromatography (from 9:1 hexane-EtOAc to 85:15 
hexane-EtOAc): []22D + 2.71 (c 0.65, EtOH); IR (film) 1772, 1712 cm
-1
; 
1
H NMR (400 MHz, CDCl3, 
COSY, g-HSQC) 0.90 (d, J = 6.3 Hz, 3H, CH3), 1.15 (m, 1H, H-3), 1.45 (m, 1H, H-3), 1.65 (m, 1H, 
H-2), 1.90 (m, 2H, CH2CH2N), 1.95 (m, 1H, H-4), 2.15 (m, 1H, H-4), 2.41 (s, 3H, CH3Ts), 2.91 (m, 2H, 
H-1), 3.14 (m, 2H, CH2NTs), 3.64 (m, 2H, CH2NPhth), 4.86-4.99 (m, 2H, H-6), 5.73 (m, 1H, H-5), 7.26 
(d, J = 8.2 Hz, 2H, H-3Ts, H-5Ts), 7.65 (d, J = 8.2 Hz, 2H, H-2Ts, H-6Ts), 7.72 (dd, J = 5.8, 3.3 Hz, 
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2H, H-Phth), 7.84 (dd, J = 5.8, 3.3 Hz, 2H, H-Phth); 
13
C NMR (100.6 MHz, CDCl3) 17.3 (CH3), 21.4 
(CH3Ts), 27.9 (CH2CH2N), 31.0 (C-3), 31.5 (C-2), 33.4 (C-4), 35.8 (CH2NPhth), 46.7 (CH2NTs), 55.1 
(C-1), 114.5 (C-6), 123.2 (CH-Phth), 127.2 (CHTs), 129.6 (CHTs), 132.2 (C-Phth), 133.9 (CH-Phth), 
137.5 (C-4Ts), 138.5 (C-5), 143.1 (C-1Ts), 168.1 (CO); HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for 
C25H31N2O4S 455.1999; Found 455.2024. 
(S)-N-[3-(2-Methyl-N-tosyl-5-hexenylamino)propyl]-4-pentenamide (21): A solution of hydrazine 
monohydrate (56 mg, 1.1 mmol) in ethanol (1.3 mL) was added to a solution of alkene 20 (506 mg, 1.1 
mmol) in ethanol (4.5 mL), and the mixture was heated at reflux for 2.5 h. Insoluble material was 
removed by filtration, and the filtrate was concentrated to give the primary amine as a yellow oil (420 
mg), which was used without purification in the next step: 
1
H NMR (400 MHz, CDCl3) 0.87 (d, J = 
6.5 Hz, 3H, CH3), 1.10-1.15 (m, 1H), 1.42-1.46 (m, 1H), 1.70-1.75 (m, 3H), 1.95-2.00 (m, 1H), 2.06-
2.13 (m, 1H), 2.42 (s, 3H, CH3Ts), 2.66 (br.s., 2H, NH2), 2.80 (m, 2H, CH2N), 2.87-2.90 (m, 2H, 
CH2N), 3.12-3.19 (m, 2H, CH2N), 4.91-5.00 (m, 2H, CH2=CH), 5.70-5.75 (m, 1H, CH2=CH), 7.20-7.30 
(m, 2H, H-Ts), 7.60-7.70 (m, 2H, H-Ts). 4-Pentenoyl chloride (0.15 mL, 1.34 mmol) and Et3N (0.2 mL, 
1.45 mmol) were slowly added to a solution of the above amine in CH2Cl2 (3 mL), and the mixture was 
stirred at room temperature for 2.5 h. The reaction was quenched with water, and the resulting mixture 
was extracted with CH2Cl2. The combined organic extracts were dried, filtered, and concentrated under 
vacuum to give an oil. Flash chromatography (from 9:1 hexane-EtOAc to 1:1 hexane-EtOAc) afforded 
diene 21 (224 mg, 50 %) as a colorless oil: []22D + 1.9 (c 1.6, MeOH); IR (film): 3305, 1644 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3, COSY, g-HSQC)  0.86 (d, J = 6.6 Hz, 3H, CH3), 1.08-1.17 (m, 1H, CHCH2), 
1.40-1.49 (m, 1H, CHCH2), 1.70-1.76 (m, 3H, CH2CH2N, CH), 1.92-2.00 (m, 1H, H-2), 2.07-2.16 (m, 
1H, H-2), 2.28-2.31 (m, 2H, CH2=CHCH2), 2.38-2.41 (m, 2H, H-3), 2.43 (s, 3H, CH3Ts), 2.84-2.95 (m, 
2H, CHCH2N), 3.10 (t, J = 6.7 Hz, 2H, TsNCH2CH2), 3.35 (m, 2H, CH2NH), 4.93-5.10 (m, 4H, 
CH2=CH), 5.73 (m, 1H, CH2=CH), 5.84 (m, 1H, CH2=CH), 6.36 (br.s, 1H, NH), 7.31 (d, J = 8.1 Hz, 
2H, H-Ts), 7.66 (d, J = 8.1 Hz, 2H, H-Ts); 
13
C NMR (100.6 MHz, CDCl3) 17.2 (CH3), 21.4 (CH3Ts), 
28.6 (CH2CH2CH2), 29.5 (CH2=CHCH2), 30.8 (C-3), 31.4 (CH), 33.2 (CH2CH2CH=), 35.8 (C-2), 36.0 
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(CH2NH), 46.8 (TsNCH2CH2), 55.9 (CHCH2N), 114.6 (CH2=CH), 115.3 (CH2=CH), 127.0 (CH-Ts), 
129.6 (CH-Ts), 135.9 (C-4Ts), 137.0 (CH2=CH), 138.3 (CH2=CH), 143.3 (C-1Ts), 172.4 (CO); HRMS 
(ESI-TOF) m/z: [M + H]
+
 Calcd for C22H35N2O3S 407.2363; Found 407.2361.  
(S)-13-Methyl-6-oxo-1-tosyl-1,5-diaza-9-cyclotetradecene (22): Operating as described in the 
preparation of macrocycle 13, from compound 21 (101 mg, 0.25 mmol) in CH2Cl2 (10 mL) and second-
generation Grubbs catalyst (32 mg, 0.037 mmol) in anhydrous CH2Cl2 (1.24 L), diazacycle 22 (72 mg, 
77 %) was obtained as a 91:9 mixture (calculated by GC/MS) of E/Z diastereoisomers after flash 
chromatography (from 8:2 hexane-EtOAc to 3:7 hexane-EtOAc). Major diastereoisomer: IR (film): 
3300, 1647 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 0.86 (d, J = 6.6 Hz, 3H, CH3), 1.10-
1.27 (m, 2H, H-4), 1.49-1.65 (m, 2H, H-3, H-13), 1.65-1.73 (m, 1H, H-13), 1.92-2.04 (m, 2H, 
CH2CH=), 2.05-2.13 (m, 1H, H-9), 2.19-2.30 (m, 2H, CH2CH=, H-9), 2.33-2.38 (m, 1H, CH2CH=), 
2.40 (s, 3H, CH3Ts), 2.75 (dd, J = 12.6, 5.9 Hz, 1H, H-2), 2.86-2.90 (m, 1H, H-12), 2.95 (dd, J = 12.6, 
9.1 Hz, 1H, H-2), 2.98-3.02 (m, 1H, H-14), 3.16-3.24 (m, 1H, H-12), 3.29-3.37 (m, 1H, H-14), 5.22-
5.36 (m, 2H, CH=CH), 5.96 (br.s, 1H, NH), 7.26 (d, J = 8.2 Hz, 2H, H-3Ts, H-5Ts), 7.62 (d, J = 8.2 Hz, 
2H, H-2Ts, H-6Ts); 
13
C NMR (100.6 MHz, CDCl3) 17.4 (CH3), 21.4 (CH3Ts), 26.9 (C-3), 28.0 
(CH2CH=), 28.3 (C-13), 28.9 (CH2CH=), 32.0 (C-4), 36.2 (C-9), 36.4 (C-14), 44.8 (C-12), 53.5 (C-2), 
127.0 (CH-Ts), 129.5 (CH=), 129.6 (CH-Ts), 131.7 (CH=), 136.5 (C-4Ts), 143.1 (C-1Ts), 172.4 (CO); 
HRMS (ESI-TOF) m/z: [M + H]
+
 Calcd for C20H31N2O3S 379.2053; Found 379.2051.  
(S)-13-Methyl-6-oxo-1-tosyl-1,5-diazacyclotetradecane (23): A solution of alkene 22 (79 mg, 0.21 
mmol) in anhydrous MeOH (7 mL) containing 10 % Pd-C (8 mg) was stirred under hydrogen at room 
temperature for 48 h. The catalyst was removed by filtration and washed with hot MeOH. The combined 
organic solutions were concentrated to give pure compound 23 (74 mg, 94 %) as a brown oil: []22D – 
12.7 (c 1.18, CHCl3); IR (film): 3410, 1643 cm
-1
; 
1
H NMR (400 MHz, CDCl3, COSY, g-HSQC) 0.89 
(d, J = 6.5 Hz, 3H, CH3), 1.10-1.20 (m, 1H, 1H-CH2), 1.22-1.35 (m, 6H, 3CH2), 1.36-1.62 (m, 3H, CH2, 
1H-CH2), 1.65-1.92 (m, 3H, H-3, CH2), 2.10-2.27 (m, 2H, H-9), 2.42 (s, 3H, CH3Ts), 2.76 (dd, J = 12.9, 
5.5 Hz, 1H, H-2), 2.99 (dd, J = 12.9, 8.5 Hz, 1H, H-2), 2.95-2.98 (m, 1H, H-14), 3.07-3.14 (m, 2H, H-
 32 
12), 3.42-3.54 (m, 1H, H-14), 6.10 (br.s, 1H, NH), 7.29 (d, J = 8.2 Hz, 2H, H-3Ts, H-5Ts), 7.65 (d, J = 
8.2 Hz, 2H, H-2Ts, H-6Ts); 
13
C NMR (100.6 MHz, CDCl3) 17.1 (CH3), 21.4 (CH3Ts), 23.3 (CH2), 
24.3 (CH2), 25.1 (CH2), 25.8 (CH2), 27.7 (C-3), 28.7 (CH2), 30.9 (CH2), 35.1 (C-9), 36.6 (C-14), 45.9 
(C-12), 54.8 (C-2), 127.1 (CH-Ts), 129.6 (CH-Ts), 136.1 (C-4Ts), 143.2 (C-1Ts), 173.1 (CO); HRMS 
(ESI-TOF) m/z: [M + H]
+
 Calcd for C20H33N2O3S 381.2206; Found 381.2207.  
(S)-Haliclorensin: A solution of diazacycle 23 (74 mg, 0.19 mmol) in dry THF (3.5 mL) was added to a 
suspension of LiAlH4 (74 mg, 1.95 mmol) in dry THF (4.5 mL) at 0 ºC, and the mixture was heated at 
reflux for 21 h. After cooling to room temperature, the reaction was quenched by water (7 mL), and the 
pH value was adjusted to 4 by adding 2 M aqueous HCl solution (2 mL). The mixture was extracted 
with Et2O, and the aqueous phase was basified with a saturated aqueous solution of K2CO3 to reach pH 
12. The solution was extracted with CH2Cl2, and the combined organic extracts were dried, filtered, and 
concentrated under vacuum to give a yellow oil. Flash chromatography (SiO2 previously washed with 
18:1:1 CH2Cl2-MeOH-NH4OH; gradient from 19:1 CH2Cl2-MeOH to 17:3 CH2Cl2-MeOH) afforded 
haliclorensin (26 mg, 65 %) as a colorless oil: []22D= – 17.2 (c 0.5, MeOH), lit
15a
 []D – 2.2 (c 1.3, 
MeOH), lit
13
 []20D – 19 (c 0.57, MeOH), lit
15b
 []D – 18.5 (c 0.6, MeOH), lit
15b
 []D – 8.5, lit
15b
 []20D 
+ 7.0 (1M HCl), lit
15c
 []20D – 18.2 (c 0.4, MeOH); 
1
H NMR (400 MHz, CD3OD, g-HSQC; see Table 3 
in Supporting Information)  0.89 (d, J = 6.9 Hz, 3H, CH3), 1.24-1.31 (m, 1H), 1.36-1.51 (m, 9H), 1.55-
1.61 (m, 2H), 1.70-1.77 (m, 3H), 2.40 (dd, J = 11.8, 9.7 Hz, 1H), 2.55 (dd, J = 11.8, 3.8 Hz, 1H), 2.58-
2.63 (m, 1H), 2.64-2.68 (m, 2H), 2.71-2.73 (m, 2H), 2.82 (ddd, J = 11.2, 6.8, 4.0 Hz, 1H); 
13
C NMR 
(100.6 MHz, CD3OD; see Table 4 in Supporting Information) 18.8 (CH3), 22.0 (CH2), 23.2 (CH2), 
24.7 (CH2), 27.3 (CH2), 27.7 (CH2), 29.3 (CH2), 30.5 (CH), 32.7 (CH2), 47.5 (CH2N), 49.8 (CH2N), 
50.5 (CH2N), 55.6 (CH2N). 
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